| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATAD5 SRP54 DQX1 NAV3 NAV1 KIF14 ABCC2 ASCC3 TAP1 TAP2 DNAH3 TCP1 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 MLH3 NLRP10 ABCB11 ACIN1 MACF1 ATP12A ATP2A3 HSPA14 | 1.46e-11 | 441 | 234 | 26 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1A ATAD5 SRP54 DQX1 NAV3 NAV1 KIF14 ABCC2 ASCC3 TAP1 TAP2 DNHD1 DNAH3 EP400 TCP1 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 MLH3 NLRP10 ABCB11 ACIN1 MACF1 ATP12A ATP2A3 HSPA14 | 1.88e-10 | 614 | 234 | 29 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATAD5 SRP54 DQX1 ERAS NAV3 NAV1 KIF14 ABCC2 ASCC3 DNM1 TAP1 TAP2 DNM2 DNAH3 TCP1 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 MLH3 NLRP10 DNM3 ABCB11 ACIN1 MACF1 ATP12A ATP2A3 HSPA14 | 9.49e-09 | 775 | 234 | 30 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATAD5 SRP54 DQX1 ERAS NAV3 NAV1 KIF14 ABCC2 ASCC3 DNM1 TAP1 TAP2 DNM2 DNAH3 TCP1 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 MLH3 NLRP10 DCP1B DNM3 ABCB11 ACIN1 MACF1 ATP12A ATP2A3 HSPA14 | 1.54e-08 | 839 | 234 | 31 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATAD5 SRP54 DQX1 ERAS NAV3 NAV1 KIF14 ABCC2 ASCC3 DNM1 TAP1 TAP2 DNM2 DNAH3 TCP1 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 MLH3 NLRP10 DCP1B DNM3 ABCB11 ACIN1 MACF1 ATP12A ATP2A3 HSPA14 | 1.59e-08 | 840 | 234 | 31 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATAD5 SRP54 DQX1 ERAS NAV3 NAV1 KIF14 ABCC2 ASCC3 DNM1 TAP1 TAP2 DNM2 DNAH3 TCP1 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 MLH3 NLRP10 DCP1B DNM3 ABCB11 ACIN1 MACF1 ATP12A ATP2A3 HSPA14 | 1.59e-08 | 840 | 234 | 31 | GO:0016818 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC26A4 SLC7A11 ABCC2 SLC23A2 SLC23A1 SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 ABCB11 SLC7A5 | 6.33e-06 | 207 | 234 | 12 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC26A4 SLC7A11 ABCC2 SLC23A2 SLC23A1 SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 ABCB11 SLC7A5 | 6.65e-06 | 208 | 234 | 12 | GO:0005342 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC26A4 SLC7A11 ABCC2 TAP1 SLC23A2 TAP2 SLC23A1 SLC13A2 SLC1A3 SLC1A6 ABCC6 SLC7A9 SLC7A8 SLC18A1 ABCB11 SLC7A5 ATP12A ATP2A3 | 1.43e-05 | 477 | 234 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC26A4 SLC7A11 ABCC2 SLC23A2 SLC23A1 SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC25A39 ABCB11 SLC7A5 | 4.50e-05 | 293 | 234 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.16e-05 | 35 | 234 | 5 | GO:0005343 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 7.87e-05 | 61 | 234 | 6 | GO:1901682 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.12e-04 | 41 | 234 | 5 | GO:0015175 | |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 1.37e-04 | 2 | 234 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | ABC-type peptide antigen transporter activity | 1.37e-04 | 2 | 234 | 2 | GO:0015433 | |
| GeneOntologyMolecularFunction | L-ascorbic acid transmembrane transporter activity | 1.37e-04 | 2 | 234 | 2 | GO:0015229 | |
| GeneOntologyMolecularFunction | L-ascorbate:sodium symporter activity | 1.37e-04 | 2 | 234 | 2 | GO:0008520 | |
| GeneOntologyMolecularFunction | tapasin binding | 1.37e-04 | 2 | 234 | 2 | GO:0046980 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.84e-04 | 71 | 234 | 6 | GO:0015179 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.65e-04 | 49 | 234 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.65e-04 | 49 | 234 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 3.00e-04 | 109 | 234 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.79e-04 | 81 | 234 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 4.07e-04 | 3 | 234 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 4.07e-04 | 3 | 234 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 4.51e-04 | 31 | 234 | 4 | GO:0005310 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 6.47e-04 | 34 | 234 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 6.51e-04 | 15 | 234 | 3 | GO:0005313 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 6.51e-04 | 15 | 234 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC26A4 SLC7A11 KCNA2 SLC7A5P2 ABCC2 TAP1 SLC23A2 TAP2 SLC23A1 AQP10 RHBG MFSD9 SLC13A2 SLC1A3 SLC1A6 ABCC6 SLC7A9 SLC7A8 CACNG8 P2RX6 SLC18A1 SLC25A39 ABCB11 SLC7A5 ATP12A SLC7A5P1 ATP2A3 | 6.86e-04 | 1180 | 234 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A4 SLC7A11 SLC23A2 SLC23A1 SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC18A1 SLC7A5 | 7.75e-04 | 296 | 234 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | ABC-type peptide transporter activity | 8.08e-04 | 4 | 234 | 2 | GO:0015440 | |
| GeneOntologyMolecularFunction | microtubule binding | NEIL2 EML2 TOGARAM1 NAV3 KIF14 DNM1 DNM2 SGIP1 DNM3 MACF1 SNCA | 1.07e-03 | 308 | 234 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.14e-03 | 18 | 234 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | XIRP1 MYO1A NEIL2 PDLIM7 EML2 TOGARAM1 EPB41L3 TTBK1 MRTFB KCNA2 SYNE2 NAV3 KIF14 DNM1 ALDOA ALDOB DNM2 ESPN FLNA FLNC SGIP1 RHBG DNM3 MACF1 SNCA | 1.18e-03 | 1099 | 234 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | transporter activity | SLC26A4 SLC7A11 KCNA2 SLC7A5P2 ABCC2 TAP1 SLC23A2 TAP2 SLC23A1 AQP10 RHBG MFSD9 APOB SLC13A2 SLC1A3 SLC1A6 ABCC6 SLC7A9 SLC7A8 CACNG8 P2RX6 SLC18A1 SLC25A39 ABCB11 SLC7A5 ATP12A SLC7A5P1 ATP2A3 | 1.20e-03 | 1289 | 234 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 1.34e-03 | 5 | 234 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 1.34e-03 | 5 | 234 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.45e-03 | 42 | 234 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.49e-03 | 105 | 234 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 1.56e-03 | 20 | 234 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 1.98e-03 | 111 | 234 | 6 | GO:0003727 | |
| GeneOntologyMolecularFunction | L-leucine transmembrane transporter activity | 1.99e-03 | 6 | 234 | 2 | GO:0015190 | |
| GeneOntologyMolecularFunction | fructose binding | 1.99e-03 | 6 | 234 | 2 | GO:0070061 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 2.08e-03 | 22 | 234 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | ADP binding | 2.39e-03 | 48 | 234 | 4 | GO:0043531 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 2.68e-03 | 24 | 234 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 2.76e-03 | 7 | 234 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.81e-03 | 119 | 234 | 6 | GO:0015294 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC7A11 SLC7A5P2 SLC23A2 SLC23A1 GRM1 SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC7A5 SLC7A5P1 | 4.03e-07 | 163 | 236 | 12 | GO:1905039 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC7A11 SLC7A5P2 SLC23A2 SLC23A1 GRM1 SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC7A5 SLC7A5P1 | 5.23e-07 | 167 | 236 | 12 | GO:1903825 |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | SLC7A11 SLC7A5P2 GRM1 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC7A5 SLC7A5P1 | 6.82e-07 | 87 | 236 | 9 | GO:1902475 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | PNKP ITGA6 TOGARAM1 PLXND1 RREB1 WNK1 TTBK1 AHNAK NAV3 MMP9 DNM1 GNL3 DNM2 ESPN ATMIN PLXNA3 VLDLR FLNA GNL3L SGIP1 ADAMTS1 TCP1 SMC4 MACROH2A1 SKIL WDR45 NOX1 ISG15 TRIM28 DNM3 NUMB MACF1 ROBO1 PAN3 SNCA INO80B | 2.36e-06 | 1366 | 236 | 36 | GO:0051130 |
| GeneOntologyBiologicalProcess | L-amino acid transport | SLC7A11 SLC7A5P2 GRM1 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC7A5 SLC7A5P1 | 4.22e-06 | 108 | 236 | 9 | GO:0015807 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC26A4 SLC7A11 SLC7A5P2 ABCC2 SLC23A2 SLC23A1 GRM1 SLC13A2 SLC1A3 SLC1A6 ABCC6 SLC7A9 SLC7A8 ABCB11 SLC7A5 SNCA SLC7A5P1 | 5.45e-06 | 410 | 236 | 17 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC26A4 SLC7A11 SLC7A5P2 ABCC2 SLC23A2 SLC23A1 GRM1 SLC13A2 SLC1A3 SLC1A6 ABCC6 SLC7A9 SLC7A8 ABCB11 SLC7A5 SNCA SLC7A5P1 | 5.81e-06 | 412 | 236 | 17 | GO:0015849 |
| GeneOntologyBiologicalProcess | siRNA-mediated post-transcriptional gene silencing | 5.87e-06 | 4 | 236 | 3 | GO:0140766 | |
| GeneOntologyBiologicalProcess | siRNA-mediated gene silencing by mRNA destabilization | 5.87e-06 | 4 | 236 | 3 | GO:0090625 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | SLC7A11 SLC7A5P2 GRM1 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC7A5 SLC7A5P1 | 1.00e-05 | 120 | 236 | 9 | GO:0003333 |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 1.45e-05 | 5 | 236 | 3 | GO:0046967 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to chromosome, telomeric region | 2.07e-05 | 15 | 236 | 4 | GO:1904814 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC26A4 SLC7A11 SLC7A5P2 ABCC2 SLC23A2 SLC23A1 GRM1 SLC13A2 SLC1A3 SLC1A6 ABCC6 SLC7A9 SLC7A8 SLC25A39 ABCB11 SLC7A5 SNCA SLC7A5P1 | 2.90e-05 | 515 | 236 | 18 | GO:0015711 |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 5.18e-05 | 58 | 236 | 6 | GO:0089718 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 5.66e-05 | 19 | 236 | 4 | GO:0098712 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 6.29e-05 | 60 | 236 | 6 | GO:0015804 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 7.29e-05 | 120 | 236 | 8 | GO:0006835 | |
| GeneOntologyBiologicalProcess | amino acid transport | SLC7A11 SLC7A5P2 GRM1 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC7A5 SNCA SLC7A5P1 | 8.70e-05 | 195 | 236 | 10 | GO:0006865 |
| GeneOntologyBiologicalProcess | RNA secondary structure unwinding | 1.18e-04 | 9 | 236 | 3 | GO:0010501 | |
| GeneOntologyBiologicalProcess | RISC complex assembly | 1.67e-04 | 10 | 236 | 3 | GO:0070922 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ITGA6 PLXND1 RREB1 DNM2 ESPN ATMIN PLXNA3 VLDLR FLNA ADAMTS1 SKIL NOX1 DNM3 NUMB MACF1 ROBO1 | 1.94e-04 | 494 | 236 | 16 | GO:0031346 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 2.28e-04 | 11 | 236 | 3 | GO:0016185 | |
| GeneOntologyCellularComponent | apical part of cell | MYO1A SLC26A4 SLC7A11 PLD1 ABCC2 SLC23A2 SLC23A1 VLDLR AQP10 GPR143 SLC13A2 ABCC6 SLC7A9 SLC7A8 ABCB11 NUMB SLC7A5 ATP12A PDZD2 | 5.48e-05 | 592 | 239 | 19 | GO:0045177 |
| GeneOntologyCellularComponent | basal plasma membrane | EPPK1 MYO1A ITGA6 SLC23A2 SLC23A1 AQP10 RHBG SLC1A3 ABCC6 SLC7A8 ABCB11 NUMB SLC7A5 ATP12A | 6.17e-05 | 354 | 239 | 14 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | EPPK1 MYO1A ITGA6 SLC23A2 AQP10 RHBG SLC1A3 ABCC6 SLC7A8 ABCB11 NUMB SLC7A5 ATP12A | 8.63e-05 | 320 | 239 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | EPPK1 MYO1A ITGA6 SLC23A2 SLC23A1 AQP10 RHBG SLC1A3 ABCC6 SLC7A8 ABCB11 NUMB SLC7A5 ATP12A | 1.24e-04 | 378 | 239 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | cell projection membrane | SLC26A4 PLXND1 ITGA5 EPB41L3 SLC7A11 KCNA2 SYNE2 ABCC2 DNM2 SLC7A9 SLC7A8 CACNG8 MACF1 ROBO1 SLC7A5 | 1.41e-04 | 431 | 239 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | apical plasma membrane | MYO1A SLC26A4 PLD1 ABCC2 SLC23A2 SLC23A1 AQP10 GPR143 SLC13A2 ABCC6 SLC7A9 SLC7A8 ABCB11 NUMB SLC7A5 ATP12A | 1.64e-04 | 487 | 239 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | inner dynein arm | 1.67e-04 | 10 | 239 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | RISC-loading complex | 1.67e-04 | 10 | 239 | 3 | GO:0070578 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.75e-04 | 25 | 239 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.71e-04 | 78 | 239 | 6 | GO:0001917 | |
| GeneOntologyCellularComponent | brush border | 3.71e-04 | 152 | 239 | 8 | GO:0005903 | |
| GeneOntologyCellularComponent | TAP complex | 3.88e-04 | 3 | 239 | 2 | GO:0042825 | |
| GeneOntologyCellularComponent | supramolecular fiber | EPPK1 MYO1A PDLIM7 INPP5D EML2 TOGARAM1 AHNAK SYNE2 NAV3 NAV1 KIF14 DNM1 ALDOA DNM2 ESPN WHRN FLNA COL6A3 FLNC DNAH3 TCP1 DNAH2 ARHGAP4 DNM3 MACF1 LTBP1 SNCA | 4.71e-04 | 1179 | 239 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EPPK1 MYO1A PDLIM7 INPP5D EML2 TOGARAM1 AHNAK SYNE2 NAV3 NAV1 KIF14 DNM1 ALDOA DNM2 ESPN WHRN FLNA COL6A3 FLNC DNAH3 TCP1 DNAH2 ARHGAP4 DNM3 MACF1 LTBP1 SNCA | 5.22e-04 | 1187 | 239 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | main axon | 5.53e-04 | 89 | 239 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | leading edge membrane | 7.24e-04 | 210 | 239 | 9 | GO:0031256 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 7.38e-04 | 94 | 239 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | chromatin | SUPT20HL1 SP2 SP4 BRPF3 GON4L SUPT20HL2 TOX4 NFATC4 BRD1 ALDOA NPAS1 FOXM1 EXOSC10 EP400 TCP1 BICRA FOSL2 NSD1 CHD8 MACROH2A1 SIM1 RFX7 RFX1 PHC1 ZNF711 KANSL3 TRIM28 SIX5 TSPYL5 ELF1 INO80B | 7.99e-04 | 1480 | 239 | 31 | GO:0000785 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.11e-03 | 223 | 239 | 9 | GO:0098862 | |
| GeneOntologyCellularComponent | P-body | 1.13e-03 | 102 | 239 | 6 | GO:0000932 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.25e-03 | 104 | 239 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | perinucleolar compartment | 1.27e-03 | 5 | 239 | 2 | GO:0097356 | |
| GeneOntologyCellularComponent | intracellular canaliculus | 1.27e-03 | 5 | 239 | 2 | GO:0046691 | |
| GeneOntologyCellularComponent | axon | MYO1A PLXND1 EPB41L3 GPRIN1 KCNA2 NTM NAV1 BSN DNM1 DNM2 WHRN FLNA CAD GRM1 GRM4 ARHGAP4 SLC18A1 CD40 DNM3 ROBO1 SNCA | 1.43e-03 | 891 | 239 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.59e-03 | 109 | 239 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.94e-03 | 22 | 239 | 3 | GO:0031258 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1A PDLIM7 PLXND1 ITGA5 EPB41L3 KCNA2 SYNE2 PLD1 DNM2 SH3RF1 SCYL3 CACNG8 MACF1 ROBO1 | 1.94e-03 | 500 | 239 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | anchoring junction | XIRP1 EPPK1 RPLP2 PDLIM7 ITGA6 ITGA5 EPB41L3 KCNA2 AHNAK SYNE2 ABCC2 WNK4 DNM2 ESPN FLNA FLNC PCDHA10 CDH19 NOX1 ABCB11 NUMB PDZD2 | 1.94e-03 | 976 | 239 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | lipid droplet | 2.19e-03 | 116 | 239 | 6 | GO:0005811 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.24e-03 | 80 | 239 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | cell body | MYO1A PLXND1 TTBK1 KCNA2 ACAN BRD1 BSN WNK4 WHRN FLNA CAD TCP1 APOB GRM1 SLC1A3 P2RX6 CD40 ROBO1 LTBP1 SNCA SORL1 | 2.37e-03 | 929 | 239 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.57e-03 | 161 | 239 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | sex chromatin | 2.63e-03 | 7 | 239 | 2 | GO:0001739 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 2.63e-03 | 7 | 239 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | actin cytoskeleton | XIRP1 MYO1A PDLIM7 INPP5D AHNAK ALDOA DNM2 ESPN WHRN FLNA FLNC MST1R MACF1 SNCA ATP12A | 2.71e-03 | 576 | 239 | 15 | GO:0015629 |
| Domain | P-loop_NTPase | PNKP MYO1A ATAD5 SRP54 DQX1 ERAS NAV3 NAV1 KIF14 ABCC2 CAMTA1 ASCC3 DNM1 HS3ST3B1 TAP1 TAP2 GNL3 DNM2 DNHD1 DNAH3 GNL3L EP400 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 URGCP NLRP10 DNM3 ABCB11 | 2.29e-08 | 848 | 233 | 32 | IPR027417 |
| Domain | AAA | ATAD5 SRP54 NAV3 NAV1 ABCC2 ASCC3 TAP1 TAP2 DNAH3 DNAH2 RNF213 ABCC6 ABCB11 | 3.15e-08 | 144 | 233 | 13 | SM00382 |
| Domain | AAA+_ATPase | ATAD5 SRP54 NAV3 NAV1 ABCC2 ASCC3 TAP1 TAP2 DNAH3 DNAH2 RNF213 ABCC6 ABCB11 | 3.15e-08 | 144 | 233 | 13 | IPR003593 |
| Domain | - | PNKP ATAD5 SRP54 DQX1 ERAS NAV3 NAV1 ABCC2 ASCC3 DNM1 HS3ST3B1 TAP1 TAP2 GNL3 DNM2 DNHD1 DNAH3 GNL3L EP400 DNAH2 SMC4 RNF213 YTHDC2 CHD8 ABCC6 URGCP NLRP10 DNM3 ABCB11 | 5.93e-08 | 746 | 233 | 29 | 3.40.50.300 |
| Domain | L_AA_transporter | 1.92e-06 | 3 | 233 | 3 | IPR004760 | |
| Domain | Argonaute_N | 7.60e-06 | 4 | 233 | 3 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 7.60e-06 | 4 | 233 | 3 | IPR032473 | |
| Domain | ArgoL2 | 7.60e-06 | 4 | 233 | 3 | IPR032472 | |
| Domain | ArgoN | 7.60e-06 | 4 | 233 | 3 | PF16486 | |
| Domain | ArgoMid | 7.60e-06 | 4 | 233 | 3 | PF16487 | |
| Domain | ArgoL2 | 7.60e-06 | 4 | 233 | 3 | PF16488 | |
| Domain | ABC_membrane | 1.01e-05 | 24 | 233 | 5 | PF00664 | |
| Domain | AA_permease_2 | 1.54e-05 | 13 | 233 | 4 | PF13520 | |
| Domain | AA/rel_permease1 | 1.54e-05 | 13 | 233 | 4 | IPR002293 | |
| Domain | DUF1785 | 1.88e-05 | 5 | 233 | 3 | SM01163 | |
| Domain | ABC_TM1F | 2.25e-05 | 28 | 233 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 2.25e-05 | 28 | 233 | 5 | IPR011527 | |
| Domain | Dynamin_central | 3.73e-05 | 6 | 233 | 3 | IPR000375 | |
| Domain | GED | 3.73e-05 | 6 | 233 | 3 | SM00302 | |
| Domain | Dynamin_M | 3.73e-05 | 6 | 233 | 3 | PF01031 | |
| Domain | GED_dom | 3.73e-05 | 6 | 233 | 3 | IPR020850 | |
| Domain | ArgoL1 | 3.73e-05 | 6 | 233 | 3 | PF08699 | |
| Domain | ArgoL1 | 3.73e-05 | 6 | 233 | 3 | IPR014811 | |
| Domain | GED | 3.73e-05 | 6 | 233 | 3 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 3.73e-05 | 6 | 233 | 3 | IPR019762 | |
| Domain | GED | 3.73e-05 | 6 | 233 | 3 | PF02212 | |
| Domain | GED | 3.73e-05 | 6 | 233 | 3 | IPR003130 | |
| Domain | TIG | 3.77e-05 | 31 | 233 | 5 | PF01833 | |
| Domain | IPT | 4.43e-05 | 32 | 233 | 5 | IPR002909 | |
| Domain | Ig_E-set | 4.79e-05 | 104 | 233 | 8 | IPR014756 | |
| Domain | G_DYNAMIN_1 | 6.46e-05 | 7 | 233 | 3 | PS00410 | |
| Domain | DYNc | 6.46e-05 | 7 | 233 | 3 | SM00053 | |
| Domain | PIWI | 1.02e-04 | 8 | 233 | 3 | PS50822 | |
| Domain | Piwi | 1.02e-04 | 8 | 233 | 3 | SM00950 | |
| Domain | Piwi | 1.02e-04 | 8 | 233 | 3 | PF02171 | |
| Domain | Piwi | 1.02e-04 | 8 | 233 | 3 | IPR003165 | |
| Domain | AA-permease/SLC12A_dom | 1.45e-04 | 22 | 233 | 4 | IPR004841 | |
| Domain | AA_permease | 1.45e-04 | 22 | 233 | 4 | PF00324 | |
| Domain | PAZ | 1.52e-04 | 9 | 233 | 3 | PS50821 | |
| Domain | PAZ | 1.52e-04 | 9 | 233 | 3 | SM00949 | |
| Domain | PAZ | 1.52e-04 | 9 | 233 | 3 | PF02170 | |
| Domain | PAZ_dom | 1.52e-04 | 9 | 233 | 3 | IPR003100 | |
| Domain | PGLYCERATE_KINASE | 1.55e-04 | 2 | 233 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 1.55e-04 | 2 | 233 | 2 | IPR015824 | |
| Domain | - | 1.55e-04 | 2 | 233 | 2 | 3.40.50.1270 | |
| Domain | - | 1.55e-04 | 2 | 233 | 2 | 3.40.50.1260 | |
| Domain | PGK | 1.55e-04 | 2 | 233 | 2 | PF00162 | |
| Domain | Tap1/ABCB2 | 1.55e-04 | 2 | 233 | 2 | IPR013306 | |
| Domain | ABC_Tap-like | 1.55e-04 | 2 | 233 | 2 | IPR013305 | |
| Domain | Phosphoglycerate_kinase_CS | 1.55e-04 | 2 | 233 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 1.55e-04 | 2 | 233 | 2 | IPR015901 | |
| Domain | Tap2/ABCB3 | 1.55e-04 | 2 | 233 | 2 | IPR005293 | |
| Domain | ABC_transporter_CS | 1.69e-04 | 42 | 233 | 5 | IPR017871 | |
| Domain | ACTININ_2 | 1.73e-04 | 23 | 233 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.73e-04 | 23 | 233 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.73e-04 | 23 | 233 | 4 | IPR001589 | |
| Domain | ABC_tran | 3.20e-04 | 48 | 233 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.20e-04 | 48 | 233 | 5 | PS50893 | |
| Domain | IPT | 3.31e-04 | 27 | 233 | 4 | SM00429 | |
| Domain | ABC_TRANSPORTER_1 | 3.53e-04 | 49 | 233 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 3.88e-04 | 50 | 233 | 5 | IPR003439 | |
| Domain | Xan_ur_permease | 4.61e-04 | 3 | 233 | 2 | PF00860 | |
| Domain | FBA_I | 4.61e-04 | 3 | 233 | 2 | IPR000741 | |
| Domain | Xant/urac/vitC | 4.61e-04 | 3 | 233 | 2 | IPR006043 | |
| Domain | Phosphoglycerate_kinase | 4.61e-04 | 3 | 233 | 2 | IPR001576 | |
| Domain | Glycolytic | 4.61e-04 | 3 | 233 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 4.61e-04 | 3 | 233 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 4.61e-04 | 3 | 233 | 2 | PS00158 | |
| Domain | Dynein_HC_stalk | 6.30e-04 | 14 | 233 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.30e-04 | 14 | 233 | 3 | IPR013602 | |
| Domain | G_DYNAMIN_dom | 6.30e-04 | 14 | 233 | 3 | IPR030381 | |
| Domain | DHC_N2 | 6.30e-04 | 14 | 233 | 3 | PF08393 | |
| Domain | EamA | 6.30e-04 | 14 | 233 | 3 | PF00892 | |
| Domain | EamA_dom | 6.30e-04 | 14 | 233 | 3 | IPR000620 | |
| Domain | MT | 6.30e-04 | 14 | 233 | 3 | PF12777 | |
| Domain | G_DYNAMIN_2 | 6.30e-04 | 14 | 233 | 3 | PS51718 | |
| Domain | DHC_fam | 7.81e-04 | 15 | 233 | 3 | IPR026983 | |
| Domain | Dynamin_GTPase | 7.81e-04 | 15 | 233 | 3 | IPR001401 | |
| Domain | Dynamin_SF | 7.81e-04 | 15 | 233 | 3 | IPR022812 | |
| Domain | Dynein_heavy | 7.81e-04 | 15 | 233 | 3 | PF03028 | |
| Domain | Dynamin_N | 7.81e-04 | 15 | 233 | 3 | PF00350 | |
| Domain | Dynein_heavy_dom | 7.81e-04 | 15 | 233 | 3 | IPR004273 | |
| Domain | Multidrug-R_assoc | 9.15e-04 | 4 | 233 | 2 | IPR005292 | |
| Domain | CH | 1.30e-03 | 65 | 233 | 5 | SM00033 | |
| Domain | Rib_L2_dom2 | 1.36e-03 | 18 | 233 | 3 | IPR014722 | |
| Domain | - | 1.36e-03 | 18 | 233 | 3 | 2.30.30.30 | |
| Domain | YTH | 1.51e-03 | 5 | 233 | 2 | PF04146 | |
| Domain | YTH_domain | 1.51e-03 | 5 | 233 | 2 | IPR007275 | |
| Domain | YTH | 1.51e-03 | 5 | 233 | 2 | PS50882 | |
| Domain | GTP_binding_domain | 1.60e-03 | 19 | 233 | 3 | IPR006073 | |
| Domain | CH | 1.81e-03 | 70 | 233 | 5 | PF00307 | |
| Domain | PWWP | 1.87e-03 | 20 | 233 | 3 | SM00293 | |
| Domain | - | 1.93e-03 | 71 | 233 | 5 | 1.10.418.10 | |
| Domain | CH | 2.18e-03 | 73 | 233 | 5 | PS50021 | |
| Domain | - | 2.25e-03 | 6 | 233 | 2 | 3.90.1290.10 | |
| Domain | OSR1_C | 2.25e-03 | 6 | 233 | 2 | PF12202 | |
| Domain | Myb-like_dom | 2.25e-03 | 6 | 233 | 2 | IPR017877 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.25e-03 | 6 | 233 | 2 | IPR024678 | |
| Domain | CH-domain | 2.46e-03 | 75 | 233 | 5 | IPR001715 | |
| Domain | EPHD | 2.48e-03 | 22 | 233 | 3 | PS51805 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 1.15e-05 | 24 | 181 | 5 | MM17215 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 1.42e-05 | 25 | 181 | 5 | M4974 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 2.04e-05 | 5 | 181 | 3 | M22079 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | INPP5D ITGA6 ITGA5 SLC7A11 ANGPT2 APOB SLC7A9 SLC7A8 TREM1 SLC7A5 | 3.68e-05 | 158 | 181 | 10 | MM14812 |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 4.05e-05 | 6 | 181 | 3 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.05e-05 | 6 | 181 | 3 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 7.02e-05 | 7 | 181 | 3 | M46421 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 1.11e-04 | 8 | 181 | 3 | MM15082 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | PDLIM7 PLXND1 ITGA5 MMP9 DNM1 DNM2 PLXNA3 VLDLR COL6A3 ARHGEF12 DNM3 NUMB | 1.41e-04 | 261 | 181 | 12 | MM15676 |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 1.65e-04 | 9 | 181 | 3 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.65e-04 | 9 | 181 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.65e-04 | 9 | 181 | 3 | M46436 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | INPP5D ITGA6 ITGA5 SLC7A11 ANGPT2 APOB SLC7A9 SLC7A8 TREM1 SLC7A5 | 2.04e-04 | 194 | 181 | 10 | M16312 |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 2.34e-04 | 10 | 181 | 3 | M48013 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.39e-04 | 44 | 181 | 5 | M11911 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.69e-04 | 25 | 181 | 4 | M39713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 2.69e-04 | 25 | 181 | 4 | M47623 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 3.15e-04 | 26 | 181 | 4 | M13748 | |
| Pathway | REACTOME_GLUCONEOGENESIS | 3.15e-04 | 26 | 181 | 4 | MM15392 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.80e-04 | 108 | 181 | 7 | M823 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 4.81e-04 | 51 | 181 | 5 | M39457 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 5.07e-04 | 109 | 181 | 7 | MM15074 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 5.42e-04 | 13 | 181 | 3 | M46434 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 6.83e-04 | 14 | 181 | 3 | M10122 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 7.14e-04 | 32 | 181 | 4 | M48012 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 7.14e-04 | 32 | 181 | 4 | MM14957 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 7.75e-04 | 117 | 181 | 7 | M19248 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 8.04e-04 | 33 | 181 | 4 | M188 | |
| Pubmed | EPPK1 RPLP2 CUL9 EPB41L3 PGK1 SUPT5H AHNAK SYNE2 KIF14 ASCC3 NOP2 GNL3 DNM2 FLNA FLNC EXOSC10 CAD TCOF1 SMC4 NSD1 YTHDC2 CHD8 HUWE1 KRR1 UTP4 ACIN1 MACF1 TP53BP1 RAI1 | 2.11e-15 | 653 | 239 | 29 | 22586326 | |
| Pubmed | AGO2 ARMCX4 EPB41L3 PGK1 EMSY KCNA2 SYNE2 NAV1 BSN DNM1 NOP2 DNM2 DNAJC13 CAD SGIP1 TCOF1 NSD1 ARHGEF12 CHD8 MACROH2A1 HUWE1 GRM1 GRM4 SLC1A3 WDR45 AGO1 ZC2HC1A TRIM28 TBK1 DNM3 MACF1 FRMPD3 TP53BP1 RAI1 | 5.89e-15 | 963 | 239 | 34 | 28671696 | |
| Pubmed | BRPF3 SPAM1 AGO2 ATAD5 CUL9 RREB1 EPB41L3 PLD1 TAF4B ASCC3 BRD1 ILVBL GNL3 ZNF687 VLDLR GNL3L EP400 TCOF1 ADAMTS1 BICRA RNF213 YTHDC2 CHD8 MACROH2A1 SKIL ZNF711 ARHGAP4 MLH3 TIMM21 TRIM28 TBK1 MACF1 INO80B RAI1 SORL1 | 7.35e-14 | 1116 | 239 | 35 | 31753913 | |
| Pubmed | AGO2 PDLIM7 GPRIN1 EMSY TOX4 MRTFB AHNAK KIF14 ASCC3 MED17 FLNA EXOSC10 CAD EP400 TCOF1 TCP1 SMC4 NSD1 CHD8 HUWE1 RFX1 TRIM28 ACIN1 NUMB TP53BP1 | 1.16e-13 | 549 | 239 | 25 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATAD5 SRP54 RRBP1 EPB41L3 GPRIN1 WNK1 PGK1 EMSY TOX4 MRTFB AHNAK ALDOA NOP2 YTHDF2 GNL3 DNM2 FLNA EXOSC10 GNL3L EP400 TCOF1 TCP1 YTHDC2 MACROH2A1 TRIM28 UTP4 ACIN1 NUMB MACF1 TP53BP1 | 2.89e-12 | 934 | 239 | 30 | 33916271 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 RPLP2 PDLIM7 RRBP1 PGK1 SUPT5H AHNAK SYNE2 KIF14 ASCC3 NOP2 TAP1 GNL3 FLNA FLNC EXOSC10 CAD EP400 TCOF1 TCP1 SMC4 YTHDC2 MACROH2A1 HUWE1 EDIL3 TRIM28 UTP4 TBK1 ACIN1 MACF1 SNRPA | 5.52e-12 | 1024 | 239 | 31 | 24711643 |
| Pubmed | RPLP2 VPS13C PLXND1 EPB41L3 GPRIN1 PGK1 CDCA2 SYDE2 AHNAK PLD1 ALDOA NOP2 HSPE1 EXOSC10 DNAJC13 EP400 TCOF1 TCP1 DNAJC16 SCYL3 RNF213 APOB HUWE1 TMEM263 LIPE ROBO1 SLC7A5 | 6.50e-12 | 777 | 239 | 27 | 35844135 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 CUL9 EML2 PLXND1 ITGA5 WNK1 AHNAK NAV1 TTC5 ZNF687 ATMIN PLXNA3 FLNA FLNC CRYBG2 FRAS1 SH3RF1 EP400 BICRA FOSL2 NSD1 CHD8 HUWE1 ECE1 GBA2 KANSL3 MST1R TRIM28 SLC25A39 SLC7A5 ATP2A3 RAI1 | 7.72e-12 | 1105 | 239 | 32 | 35748872 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPPK1 PDLIM7 ITGA6 SRP54 EPB41L3 GPRIN1 WNK1 PGK1 EMSY TOX4 MRTFB SUPT5H NTM AHNAK SYNE2 ALDOA NOP2 ILVBL HSPE1 FLNA FLNC DNAJC13 TCOF1 TCP1 SMC4 RNF213 MACROH2A1 HUWE1 ZC2HC1A CD40 ACIN1 NUMB TSPYL5 SLC7A5 TP53BP1 | 2.25e-11 | 1367 | 239 | 35 | 32687490 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPLP2 VPS13C KIAA0586 RRBP1 EPB41L3 PGK1 CDCA2 SUPT5H KIF14 MMP9 BSN ALDOA NOP2 GNL3 DNHD1 HSPE1 FLNA CAD GNL3L TCOF1 TCP1 SMC4 YTHDC2 APOB MACROH2A1 HUWE1 GRM1 KRR1 TRIM28 UTP4 TBK1 PUS1 ACIN1 SLC7A5 SNRPA | 6.96e-11 | 1425 | 239 | 35 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AGO2 RPLP2 PDLIM7 SRP54 RRBP1 EPB41L3 PGK1 CDCA2 AHNAK ASCC3 ALDOA NOP2 YTHDF2 GNL3 FLNA FLNC EXOSC10 DNAJC13 CAD GNL3L EP400 TCP1 SMC4 CHD8 MACROH2A1 HUWE1 KRR1 ZC2HC1A TRIM28 UTP4 ACIN1 MACF1 SNRPA TP53BP1 | 7.36e-11 | 1353 | 239 | 34 | 29467282 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATAD5 RRBP1 RREB1 EPB41L3 EMSY CDCA2 TOX4 AHNAK ALDOA NOP2 YTHDF2 GNL3 FLNA EXOSC10 EP400 BICRA NSD1 CHD8 MACROH2A1 KRR1 RFX1 ZNF711 TRIM28 ACIN1 SNRPA INO80B TP53BP1 RAI1 | 1.29e-10 | 954 | 239 | 28 | 36373674 |
| Pubmed | SP2 AGO2 ATAD5 GON4L CUL9 RREB1 EMSY CDCA2 NFATC4 SYNE2 MED17 NOP2 YTHDF2 ILVBL GNL3 ZNF687 HSPE1 CAD EP400 TCP1 BICRA CHD8 KRR1 RFX7 RFX1 KANSL3 AGO1 DCP1B SIX5 ELF1 PAN3 INO80B TP53BP1 SORL1 | 3.08e-10 | 1429 | 239 | 34 | 35140242 | |
| Pubmed | ATAD5 GON4L SRP54 EPB41L3 WNK1 CDCA2 AHNAK NAV1 KIF14 BRD1 MED17 NOP2 ZNF687 FOXM1 GNL3L EP400 HUWE1 PHC1 ZNF711 TBK1 LTBP1 RAI1 | 9.12e-10 | 645 | 239 | 22 | 25281560 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RRBP1 RREB1 GPRIN1 EMSY NOP2 ZNF687 DNM2 FOXM1 FLNA DNAJC13 EP400 TCOF1 FOSL2 YTHDC2 HUWE1 RFX7 RFX1 URGCP KANSL3 TRIM28 ACIN1 SLC7A5 ELF1 TP53BP1 | 1.01e-09 | 774 | 239 | 24 | 15302935 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 RREB1 PGK1 SUPT5H AHNAK FLNA EXOSC10 EP400 TCP1 SMC4 RNF213 CHD8 HUWE1 TRIM28 ACIN1 TP53BP1 | 1.58e-09 | 332 | 239 | 16 | 32786267 |
| Pubmed | RPLP2 RRBP1 EPB41L3 WNK1 NOP2 ZNF687 FLNA CAD TCOF1 CHD8 HUWE1 ZC2HC1A DCP1B TRIM28 PUS1 ACIN1 NUMB ELF1 TP53BP1 | 2.58e-09 | 503 | 239 | 19 | 16964243 | |
| Pubmed | GON4L CUL9 NAV3 NAV1 CAMTA1 SLC23A2 ATMIN WHRN FRAS1 EP400 DNAJC16 ARHGEF12 HEATR5A DNM3 ACIN1 MACF1 PDZD2 | 4.15e-09 | 407 | 239 | 17 | 12693553 | |
| Pubmed | PNKP RPLP2 ATAD5 EML2 RREB1 SUPT5H AHNAK ASCC3 ZNF687 GNL3L EP400 KANSL3 | 4.18e-09 | 177 | 239 | 12 | 26206133 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CUL9 WNK1 EMSY MRTFB SUPT5H NAV1 KIF14 BSN FOXM1 CAD SH3RF1 EP400 TCOF1 HUWE1 KANSL3 UTP4 TBK1 MACF1 TP53BP1 SORL1 | 5.74e-09 | 588 | 239 | 20 | 38580884 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 PNKP RPLP2 ATAD5 RRBP1 RREB1 EMSY CDCA2 TOX4 SUPT5H AHNAK MED17 NOP2 ILVBL GNL3 ZNF687 EXOSC10 EP400 TCOF1 FOSL2 NSD1 RFX7 SKIL KANSL3 TRIM28 UTP4 ACIN1 SLC7A5 SNRPA RAI1 | 6.81e-09 | 1294 | 239 | 30 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SP2 RPLP2 RRBP1 RREB1 EMSY RCC1L TOX4 AHNAK ASCC3 NOP2 ILVBL GNL3 ZNF687 DNM2 FLNA CAD EP400 TCOF1 TCP1 SMC4 CHD8 MACROH2A1 HUWE1 KRR1 KANSL3 TRIM28 UTP4 PUS1 ACIN1 SNRPA | 1.03e-08 | 1318 | 239 | 30 | 30463901 |
| Pubmed | BRPF3 CUL9 EPB41L3 DNM1 SLC23A1 DNM2 CCR10 FLNA FLNC BICRA PCDHA11 PCDHA10 MACROH2A1 DNM3 ATP2A3 | 1.09e-08 | 329 | 239 | 15 | 17474147 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EPPK1 AGO2 RRBP1 RCC1L SUPT5H ASCC3 DNM1 ALDOA NOP2 YTHDF2 GNL3 FLNA EXOSC10 TCOF1 TCP1 YTHDC2 KRR1 AGO1 TRIM28 PUS1 ACIN1 MACF1 SNRPA | 1.10e-08 | 807 | 239 | 23 | 22681889 |
| Pubmed | PNKP AGO2 RPLP2 PGK1 AGO4 AHNAK KIF14 PLD1 ASCC3 MED17 ALDOA TAP1 TAP2 ILVBL GNL3 FLNA EXOSC10 DNAJC13 CAD GNL3L RNF213 HUWE1 KRR1 ECE1 NBAS DCP1B SLC7A5 HSPA14 | 1.11e-08 | 1168 | 239 | 28 | 19946888 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RPLP2 RRBP1 CDCA2 SUPT5H ASCC3 MED17 NOP2 ZNF687 EXOSC10 CAD EP400 TCOF1 YTHDC2 CHD8 HUWE1 TRIM28 TP53BP1 | 1.31e-08 | 440 | 239 | 17 | 34244565 |
| Pubmed | SP4 INPP5D SRP54 RREB1 PGK1 EMSY MED17 ALDOA NOP2 ZNF687 DNM2 FLNA EXOSC10 CAD EP400 TCP1 BICRA FOSL2 SMC4 CHD8 RFX1 KHDC4 KANSL3 ELF1 SNRPA TP53BP1 RAI1 | 1.35e-08 | 1103 | 239 | 27 | 34189442 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPPK1 RPLP2 ITGA6 RRBP1 PGK1 AHNAK NAV1 KIF14 ASCC3 ALDOA NOP2 YTHDF2 GNL3 FLNA EXOSC10 CAD GNL3L TCP1 SMC4 YTHDC2 MACROH2A1 KRR1 EDIL3 TRIM28 UTP4 ACIN1 SLC7A5 SNRPA HSPA14 | 1.38e-08 | 1257 | 239 | 29 | 36526897 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | PNKP EPPK1 ATAD5 GON4L RRBP1 AHNAK ZNF687 DNM2 EP400 SMC4 CHD8 MACROH2A1 KRR1 SNRPA TP53BP1 RAI1 | 1.78e-08 | 394 | 239 | 16 | 27248496 |
| Pubmed | EPPK1 RPLP2 SRP54 RRBP1 ITGA5 WNK1 AHNAK SYNE2 TAP1 YTHDF2 ILVBL GNL3 DNM2 HSPE1 FLNA DNAJC13 CAD TCOF1 TCP1 SMC4 APOB ECE1 ISG15 TBK1 NUMB MACF1 ROBO1 SNRPA TP53BP1 | 2.73e-08 | 1297 | 239 | 29 | 33545068 | |
| Pubmed | RREB1 EPB41L3 TOX4 MRTFB AHNAK NAV1 KIF14 ASCC3 ZNF687 FLNA DNAJC13 CHD8 HUWE1 RFX1 PHC1 TBK1 | 4.03e-08 | 418 | 239 | 16 | 34709266 | |
| Pubmed | TOGARAM1 SNRK RRBP1 WNK1 MRTFB SYNE2 CAMTA1 SLC23A2 DNAJC16 CHD8 DNM3 MACF1 | 6.05e-08 | 225 | 239 | 12 | 12168954 | |
| Pubmed | RRBP1 EPB41L3 PGK1 NOP2 YTHDF2 GNL3 FLNA FLNC EXOSC10 CAD TCP1 SMC4 YTHDC2 HUWE1 KRR1 TRIM28 PUS1 SNRPA | 6.24e-08 | 551 | 239 | 18 | 34728620 | |
| Pubmed | CUL9 EPB41L3 TTBK1 KIF14 CFAP70 TAF4B MMP9 GNL3 EXOSC10 DNAJC13 CAD APOB HUWE1 KRR1 AGO1 MACF1 SNRPA | 7.42e-08 | 496 | 239 | 17 | 31343991 | |
| Pubmed | PECR AGO2 SRP54 RRBP1 PGK1 RCC1L TOX4 AHNAK PLD1 ASCC3 ALDOA NOP2 YTHDF2 GNL3 FLNA EXOSC10 GNL3L EP400 TCOF1 TCP1 APOB MACROH2A1 KRR1 TMEM263 KANSL3 TBK1 ACIN1 NUMB HSPA14 | 8.88e-08 | 1371 | 239 | 29 | 36244648 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | EPPK1 RPLP2 PLXND1 WNK1 AHNAK FLNA FLNC CAD TCP1 SMC4 TRIM28 TP53BP1 | 9.72e-08 | 235 | 239 | 12 | 30258100 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | EMSY TOX4 MRTFB NOP2 ZNF687 EP400 TCOF1 SMC4 RNF213 CHD8 RFX1 PUS1 ACIN1 TP53BP1 | 1.24e-07 | 341 | 239 | 14 | 32971831 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPLP2 SRP54 EPB41L3 SUPT5H DNM1 MED17 HSPE1 FLNC EXOSC10 DNAJC13 CAD EP400 TCOF1 MACROH2A1 SIM1 EDIL3 AGO1 ZC2HC1A TRIM28 DNM3 ACIN1 MACF1 TSPYL5 PAN3 SNRPA | 1.44e-07 | 1082 | 239 | 25 | 38697112 |
| Pubmed | PNKP PDLIM7 RRBP1 TOX4 MRTFB SUPT5H ASCC3 BRD1 DNM2 FLNA FLNC HUWE1 SKIL RFX1 IL36RN DCP1B MACF1 SNRPA | 1.76e-07 | 591 | 239 | 18 | 15231748 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | NEIL2 TOX4 ALDOA YTHDF2 GNL3 HSPE1 DNAH3 FRAS1 GNL3L EP400 TCOF1 TCP1 CHD8 DNM3 ACIN1 | 1.93e-07 | 410 | 239 | 15 | 26949251 |
| Pubmed | VPS13C RRBP1 RREB1 WNK1 NFATC4 NAV1 KIF14 YTHDF2 GNL3 ZNF687 GNL3L EP400 DNAJC16 MFSD9 RNF213 HUWE1 NBAS DCP1B ROBO1 SLC7A5 | 2.09e-07 | 733 | 239 | 20 | 34672954 | |
| Pubmed | 2.67e-07 | 9 | 239 | 4 | 15901826 | ||
| Pubmed | RPLP2 RRBP1 PIGR MMP9 ALDOA NOP2 GNL3 FLNA EXOSC10 CAD TCP1 YTHDC2 MACROH2A1 KRR1 TRIM28 UTP4 | 2.86e-07 | 483 | 239 | 16 | 36912080 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RPLP2 PDLIM7 ITGA6 ITGA5 SLC7A11 AHNAK ALDOA NOP2 TAP1 TAP2 ILVBL ZNF687 FLNA FLNC DNAJC13 TCOF1 CHD8 MACROH2A1 RFX1 ZNF711 TIMM21 TRIM28 UTP4 CD40 SLC7A5 TP53BP1 | 2.89e-07 | 1203 | 239 | 26 | 29180619 |
| Pubmed | AGO2 ATAD5 PDLIM7 ITGA6 ITGA5 GPRIN1 CDCA2 TOX4 SUPT5H AHNAK SYNE2 KIF14 DNAJC13 CAD TCP1 SCYL3 RNF213 HUWE1 POSTN PUS1 NUMB ROBO1 LTBP1 SETD7 | 3.10e-07 | 1049 | 239 | 24 | 27880917 | |
| Pubmed | 3.15e-07 | 130 | 239 | 9 | 12421765 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 12511974 | ||
| Pubmed | Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins. | 3.20e-07 | 3 | 239 | 3 | 19946268 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 24273169 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 12383797 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 3.20e-07 | 3 | 239 | 3 | 28395327 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 3.20e-07 | 3 | 239 | 3 | 24046449 | |
| Pubmed | EPPK1 AGO2 VPS13C SYNE2 KIF14 NOP2 ILVBL ZNF687 FOXM1 FLNA CAD EP400 TCOF1 DNAH2 SMC4 APOB ECE1 SLC1A6 TMEM263 SNRPA | 3.26e-07 | 754 | 239 | 20 | 35906200 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP4 EPPK1 PDLIM7 INPP5D WNK1 MRTFB NFATC4 CAMTA1 BSN WNK4 EP400 TCOF1 BICRA GRM1 NUMB | 3.54e-07 | 430 | 239 | 15 | 35044719 |
| Pubmed | SNRK RRBP1 EPB41L3 GPRIN1 DHRS1 PGK1 NAV3 NAV1 BSN ALDOA HSPE1 FLNA CAD SGIP1 DNAJC16 MACROH2A1 HUWE1 SLC1A3 CACNG8 MECR TRIM28 MACF1 SLC7A5 SNCA TP53BP1 | 3.74e-07 | 1139 | 239 | 25 | 36417873 | |
| Pubmed | SP2 KIAA0586 TOGARAM1 EPB41L3 WNK1 TOX4 TTBK1 PLIN4 SH3RF1 RNF213 GBA2 KHDC4 GLCE UTP4 MACF1 TSPYL5 | 3.75e-07 | 493 | 239 | 16 | 15368895 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | RPLP2 SRP54 RRBP1 EPB41L3 GPRIN1 DHRS1 TOX4 MRTFB SYNE2 ASCC3 FLNA FRAS1 DNAJC16 NBAS | 3.91e-07 | 375 | 239 | 14 | 32788342 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | VPS13C PGK1 AHNAK ASCC3 ALDOA TAP1 GNL3 FLNA CAD TCP1 RNF213 ISG15 | 4.00e-07 | 268 | 239 | 12 | 33024031 |
| Pubmed | PDLIM7 VPS13C SRP54 RRBP1 EPB41L3 MRTFB AHNAK SYNE2 FLNA FLNC YTHDC2 GBA2 TMEM263 NBAS ROBO1 SLC7A5 SNCA | 4.98e-07 | 568 | 239 | 17 | 37774976 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 SRP54 EPB41L3 EMSY PIGR AHNAK ALDOA YTHDF2 FOXM1 FLNA FLNC EP400 CHD8 KANSL3 TRIM28 | 5.30e-07 | 444 | 239 | 15 | 34795231 |
| Pubmed | GON4L EPB41L3 PGK1 MRTFB SUPT5H AHNAK ASCC3 ALDOA NOP2 GNL3 FLNA TCP1 TRIM28 | 5.61e-07 | 330 | 239 | 13 | 32529326 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | PNKP MYO1A CUL9 RRBP1 EMSY NFATC4 FOXM1 FLNC EP400 FOSL2 SMC4 MACROH2A1 HUWE1 SKIL RFX1 KANSL3 SIX5 SETD7 HSPA14 TP53BP1 SORL1 | 5.93e-07 | 857 | 239 | 21 | 25609649 |
| Pubmed | EPPK1 TOX4 AHNAK NAV1 NOP2 FLNA FOSL2 NSD1 CHD8 HUWE1 KHDC4 TRIM28 MACF1 | 6.00e-07 | 332 | 239 | 13 | 37433992 | |
| Pubmed | AGO2 SUPT5H ASCC3 BRD1 GNL3 EXOSC10 RNF213 YTHDC2 MACROH2A1 HUWE1 KRR1 UTP4 ACIN1 | 6.00e-07 | 332 | 239 | 13 | 25693804 | |
| Pubmed | AGO2 PDLIM7 SRP54 EPB41L3 MRTFB AHNAK FLNA TCOF1 TCP1 SCYL3 ARHGEF12 HUWE1 TBK1 NUMB SLC7A5 | 6.10e-07 | 449 | 239 | 15 | 31732153 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPPK1 MYO1A RPLP2 PGK1 AHNAK ALDOA TAP2 YTHDF2 DNM2 HSPE1 CAD SMC4 HUWE1 ISG15 TRIM28 SNRPA ATP2A3 TP53BP1 | 6.55e-07 | 647 | 239 | 18 | 26618866 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 PDLIM7 SRP54 EPB41L3 TOX4 AHNAK DNM2 EXOSC10 DNAJC13 TCP1 SMC4 YTHDC2 CHD8 HUWE1 ACIN1 MACF1 SNRPA | 6.96e-07 | 582 | 239 | 17 | 20467437 |
| Pubmed | GON4L RRBP1 SUPT5H DNM1 YTHDF2 ILVBL DNM2 FRAS1 GNL3L TCP1 DNAJC16 YTHDC2 CHD8 ECE1 URGCP TBK1 TMEM14B SORL1 | 7.00e-07 | 650 | 239 | 18 | 38777146 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | EMSY TOX4 MRTFB SUPT5H NOP2 EXOSC10 EP400 YTHDC2 CHD8 ZNF711 TRIM28 ACIN1 | 7.11e-07 | 283 | 239 | 12 | 30585729 |
| Pubmed | EPPK1 RPLP2 ATAD5 PGK1 PIGR AHNAK ALDH3A1 ALDOA NOP2 GNL3 FLNA TCOF1 SMC4 APOB MACROH2A1 KRR1 TRIM28 SNRPA | 7.31e-07 | 652 | 239 | 18 | 31180492 | |
| Pubmed | GON4L AHNAK NOP2 GNL3 DNHD1 FLNA EXOSC10 CAD DNAJC16 NSD1 MACF1 | 7.60e-07 | 234 | 239 | 11 | 36243803 | |
| Pubmed | RPLP2 DHRS1 PGK1 AHNAK ALDOA HSPE1 FLNA FLNC CAD TCP1 SMC4 TRIM28 SNRPA ATP2A3 | 7.70e-07 | 397 | 239 | 14 | 21319273 | |
| Pubmed | MYO1A RRBP1 EPB41L3 PGK1 PGK2 CDCA2 AHNAK SYNE2 ABCC2 BSN ESPN PLXNA3 HSPE1 FLNA FLNC DNAH2 SMC4 RDH12 APOB MACROH2A1 ECE1 TIMM21 ACIN1 MACF1 SLC7A5 ATP12A ATP2A3 RAI1 | 8.33e-07 | 1442 | 239 | 28 | 35575683 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | RREB1 EMSY SYNE2 NOP2 ZNF687 CAD TCP1 SMC4 HUWE1 UTP4 ACIN1 ATP2A3 | 8.87e-07 | 289 | 239 | 12 | 23752268 |
| Pubmed | BRPF3 AGO2 VPS13C SNRK PLXND1 RRBP1 AGO4 BSN ZNF687 EP400 CHD8 URGCP KANSL3 ARHGAP4 SETD7 RAI1 | 9.48e-07 | 529 | 239 | 16 | 14621295 | |
| Pubmed | RPLP2 SRP54 RRBP1 AHNAK ASCC3 ALDOA NOP2 GNL3 HSPE1 FLNA FLNC EXOSC10 CAD TCOF1 TCP1 SMC4 TRIM28 TBK1 ACIN1 SNRPA | 9.71e-07 | 809 | 239 | 20 | 32129710 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | RREB1 PGK1 SUPT5H NOP2 GNL3 EXOSC10 YTHDC2 HUWE1 KRR1 RFX1 ZNF711 UTP4 RAI1 | 1.05e-06 | 349 | 239 | 13 | 25665578 |
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 1.28e-06 | 4 | 239 | 3 | 23748378 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 9056918 | ||
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 1.28e-06 | 4 | 239 | 3 | 22795694 | |
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 1.28e-06 | 4 | 239 | 3 | 21689597 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 19966796 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 21948796 | ||
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 1.28e-06 | 4 | 239 | 3 | 18771919 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 22846998 | ||
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 1.28e-06 | 4 | 239 | 3 | 15260970 | |
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 1.28e-06 | 4 | 239 | 3 | 17101974 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | CDCA2 TOX4 SUPT5H ASCC3 ALDOA ZNF687 FLNA EXOSC10 CAD EP400 TCP1 CHD8 TRIM28 | 1.35e-06 | 357 | 239 | 13 | 37059091 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ATAD5 RRBP1 CDCA2 TOX4 ASCC3 MED17 NOP2 YTHDF2 GNL3 EXOSC10 DNAJC13 YTHDC2 MACROH2A1 KRR1 URGCP TRIM28 ACIN1 MACF1 HSPA14 | 1.53e-06 | 759 | 239 | 19 | 35915203 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPLP2 PDLIM7 CDCA2 SUPT5H AHNAK NOP2 GNL3 HSPE1 FLNA FLNC EXOSC10 GNL3L TCOF1 TCP1 MACROH2A1 HUWE1 KRR1 TRIM28 UTP4 ACIN1 TSPYL5 TP53BP1 | 1.57e-06 | 989 | 239 | 22 | 36424410 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | RRBP1 ASCC3 NOP2 YTHDF2 GNL3 EXOSC10 CAD GNL3L TCP1 SMC4 YTHDC2 HUWE1 TRIM28 UTP4 PUS1 | 1.63e-06 | 486 | 239 | 15 | 30940648 |
| Pubmed | PNKP ATAD5 PDLIM7 GON4L SRP54 EMSY MRTFB KIF14 ASCC3 ILVBL GNL3 ZNF687 CAD GNL3L EP400 DNAJC16 FOSL2 SMC4 NSD1 ARHGEF12 YTHDC2 CHD8 KRR1 UTP4 NUMB MACF1 SLC7A5 INO80B | 1.72e-06 | 1497 | 239 | 28 | 31527615 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.83e-06 | 256 | 239 | 11 | 35777956 | |
| Pubmed | EPPK1 CUL9 RRBP1 TOX4 PIGR SUPT5H NOP2 TAP2 DNM2 TCOF1 BICRA MACROH2A1 ISG15 ACIN1 MACF1 TSPYL5 LTBP1 | 2.22e-06 | 634 | 239 | 17 | 34591612 | |
| Pubmed | RRBP1 EPB41L3 GPRIN1 AHNAK ASCC3 MED17 YTHDF2 CAD SH3RF1 TCOF1 TCP1 SMC4 ARHGEF12 YTHDC2 TRIM28 NUMB MACF1 ROBO1 | 2.34e-06 | 708 | 239 | 18 | 39231216 | |
| Pubmed | PNKP ATAD5 SRP54 RRBP1 PGK1 SUPT5H AHNAK MED17 GNL3 ZNF687 EXOSC10 CAD EP400 TCP1 SMC4 RNF213 CHD8 MACROH2A1 KANSL3 TRIM28 ACIN1 SNRPA | 2.34e-06 | 1014 | 239 | 22 | 32416067 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPPK1 RPLP2 RRBP1 AHNAK ALDOA NOP2 GNL3 FLNA CAD GNL3L TCOF1 TCP1 SMC4 APOB MACROH2A1 TRIM28 UTP4 TBK1 NUMB SLC7A5 SNRPA | 2.96e-06 | 949 | 239 | 21 | 36574265 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RRBP1 TOX4 AHNAK FLNA EXOSC10 EP400 TCOF1 CHD8 MACROH2A1 ACIN1 TP53BP1 | 3.16e-06 | 271 | 239 | 11 | 32433965 |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 19393748 | ||
| Interaction | SIRT7 interactions | EPPK1 RPLP2 CUL9 EPB41L3 PGK1 SUPT5H AHNAK SYNE2 KIF14 ASCC3 NOP2 GNL3 DNM2 FLNA FLNC EXOSC10 CAD TCOF1 SMC4 NSD1 YTHDC2 CHD8 HUWE1 KRR1 UTP4 ACIN1 MACF1 TP53BP1 RAI1 | 1.33e-08 | 744 | 235 | 29 | int:SIRT7 |
| Interaction | TOP3B interactions | EPPK1 AGO2 CUL9 EML2 PLXND1 ITGA5 WNK1 AHNAK NAV1 KIF14 TTC5 NOP2 YTHDF2 ZNF687 ATMIN PLXNA3 FLNA FLNC CRYBG2 FRAS1 CAD SH3RF1 EP400 BICRA FOSL2 NSD1 CHD8 APOB MACROH2A1 HUWE1 ECE1 GBA2 KANSL3 MST1R TRIM28 SLC25A39 ACIN1 SLC7A5 SNRPA ATP2A3 TP53BP1 RAI1 | 5.34e-08 | 1470 | 235 | 42 | int:TOP3B |
| Interaction | PML interactions | SP2 SRP54 RRBP1 EPB41L3 PGK1 EMSY PIGR AHNAK SYNE2 KIF14 BRD1 MED17 ALDOA NOP2 TAP1 TAP2 YTHDF2 ZNF687 DNM2 FOXM1 FLNA FLNC EP400 RNF213 CHD8 CDH19 SKIL KANSL3 TRIM28 TP53BP1 | 4.91e-07 | 933 | 235 | 30 | int:PML |
| Interaction | NAA40 interactions | ATAD5 SRP54 RRBP1 EPB41L3 GPRIN1 WNK1 PGK1 EMSY TOX4 MRTFB AHNAK ALDOA NOP2 YTHDF2 GNL3 DNM2 FLNA EXOSC10 GNL3L EP400 TCOF1 TCP1 YTHDC2 MACROH2A1 TRIM28 UTP4 ACIN1 NUMB MACF1 TP53BP1 | 1.30e-06 | 978 | 235 | 30 | int:NAA40 |
| Interaction | OBSL1 interactions | EPPK1 PDLIM7 CUL9 SUPT5H AHNAK SYNE2 KIF14 CFAP70 ALDOA NOP2 GNL3 FLNA FLNC EXOSC10 DNAJC13 CAD EP400 TCOF1 TCP1 MACROH2A1 HUWE1 KRR1 AGO1 TRIM28 UTP4 ACIN1 MACF1 SNRPA | 2.41e-06 | 902 | 235 | 28 | int:OBSL1 |
| Interaction | CIT interactions | PNKP EPPK1 RPLP2 PDLIM7 SRP54 PLXND1 RREB1 SUPT5H AHNAK SYNE2 KIF14 NOP2 GNL3 ZNF687 FLNA FLNC EXOSC10 CAD EP400 TCOF1 TCP1 SMC4 RNF213 YTHDC2 CHD8 APOB HEATR5A MACROH2A1 SLC1A3 NBAS TRIM28 UTP4 ACIN1 MACF1 SLC7A5 ELF1 SNRPA | 5.42e-06 | 1450 | 235 | 37 | int:CIT |
| Interaction | SUMO2 interactions | EPPK1 RREB1 PGK1 SUPT5H AHNAK ALDOA NOP2 HSPE1 FLNA EXOSC10 CAD EP400 TCP1 SMC4 RNF213 CHD8 HUWE1 TRIM28 TBK1 ACIN1 TP53BP1 | 6.37e-06 | 591 | 235 | 21 | int:SUMO2 |
| Interaction | H3C1 interactions | ATAD5 RRBP1 GPRIN1 CDCA2 AHNAK NAV3 BRD1 NOP2 GNL3 HSPE1 EXOSC10 DNAH2 NSD1 CHD8 MACROH2A1 KRR1 ZNF711 TRIM28 DNM3 PUS1 TSPYL5 SLC7A5 SETD7 SNCA SNRPA TP53BP1 PDZD2 | 7.07e-06 | 901 | 235 | 27 | int:H3C1 |
| Interaction | MKI67 interactions | NEIL2 PDLIM7 RRBP1 TOX4 KIF14 ALDOA YTHDF2 GNL3 HSPE1 DNAH3 FRAS1 GNL3L EP400 TCOF1 TCP1 DNAH2 CHD8 PPP1R3A MST1R TRIM28 DNM3 ACIN1 | 7.83e-06 | 648 | 235 | 22 | int:MKI67 |
| Interaction | SOX2 interactions | SP2 AGO2 ATAD5 SRP54 CUL9 EML2 PGK1 SUPT5H NAV3 KIF14 ABCC2 ASCC3 NOP2 YTHDF2 GNL3 ZNF687 HSPE1 FLNA COL6A3 EXOSC10 DNAJC13 EP400 TCP1 DNAJC16 NSD1 YTHDC2 CHD8 MACROH2A1 KRR1 RFX1 AGO1 ZC2HC1A TRIM28 NUMB MACF1 SETD7 | 8.80e-06 | 1422 | 235 | 36 | int:SOX2 |
| Interaction | KCNA3 interactions | EPPK1 RRBP1 EPB41L3 GPRIN1 KCNA2 AHNAK ASCC3 BSN DNM1 MED17 ALDOA YTHDF2 DNHD1 CAD SH3RF1 TCOF1 TCP1 SMC4 ARHGEF12 RNF213 YTHDC2 TRIM28 NUMB MACF1 ROBO1 SORL1 | 1.13e-05 | 871 | 235 | 26 | int:KCNA3 |
| Interaction | HDAC11 interactions | 1.36e-05 | 154 | 235 | 10 | int:HDAC11 | |
| Interaction | NUP43 interactions | GON4L EMSY CDCA2 MRTFB SYNE2 GNL3 ZNF687 FLNA GNL3L EP400 TCP1 MUC19 NSD1 CHD8 MACROH2A1 ZNF711 KANSL3 ISG15 ACIN1 ELF1 PDZD2 | 1.48e-05 | 625 | 235 | 21 | int:NUP43 |
| Interaction | SIRT6 interactions | RPLP2 RRBP1 CDCA2 SUPT5H ASCC3 MED17 NOP2 ZNF687 FLNA EXOSC10 CAD EP400 TCOF1 TCP1 SMC4 YTHDC2 CHD8 MACROH2A1 HUWE1 TRIM28 TP53BP1 | 1.59e-05 | 628 | 235 | 21 | int:SIRT6 |
| Interaction | SMC5 interactions | ATAD5 RRBP1 RREB1 EPB41L3 EMSY CDCA2 TOX4 AHNAK ALDOA NOP2 YTHDF2 GNL3 FLNA EXOSC10 EP400 BICRA NSD1 CHD8 MACROH2A1 KRR1 RFX1 ZNF711 TRIM28 ACIN1 SNRPA INO80B TP53BP1 RAI1 | 1.65e-05 | 1000 | 235 | 28 | int:SMC5 |
| Interaction | H2BC21 interactions | BRPF3 PNKP ATAD5 TOGARAM1 RREB1 EPB41L3 TOX4 MRTFB SUPT5H AHNAK BRD1 NOP2 ZNF687 DNAJC13 EP400 DNAH2 NSD1 CHD8 MACROH2A1 HUWE1 PHC1 RAI1 | 2.36e-05 | 696 | 235 | 22 | int:H2BC21 |
| Interaction | XRCC6 interactions | PNKP AGO2 EMSY CDCA2 TOX4 MRTFB SUPT5H KIF14 NOP2 ILVBL DNM2 EXOSC10 EP400 NSD1 YTHDC2 CHD8 MACROH2A1 HUWE1 SKIL ZNF711 ISG15 TRIM28 CD40 ACIN1 SNCA TP53BP1 | 3.35e-05 | 928 | 235 | 26 | int:XRCC6 |
| Interaction | AR interactions | EPPK1 VPS13C RREB1 PGK1 EMSY CDCA2 MED17 TTC5 GNL3 FLNA EXOSC10 EP400 TCP1 FOSL2 NSD1 RNF213 CHD8 MACROH2A1 HUWE1 SKIL KANSL3 MLH3 NLRP10 TRIM28 ACIN1 SETD7 RAI1 | 3.86e-05 | 992 | 235 | 27 | int:AR |
| Interaction | CAV1 interactions | ITGA6 ITGA5 EPB41L3 GPRIN1 SLC7A11 PGK1 KIF14 PLD1 DNM1 FLNA SH3RF1 SCYL3 ECE1 SLC1A3 ISG15 CD40 ACIN1 NUMB MACF1 ROBO1 SLC7A5 SNCA | 4.26e-05 | 724 | 235 | 22 | int:CAV1 |
| Interaction | TMEM9B interactions | 4.77e-05 | 111 | 235 | 8 | int:TMEM9B | |
| Interaction | XIRP1 interactions | 4.85e-05 | 18 | 235 | 4 | int:XIRP1 | |
| Interaction | CUL7 interactions | BRPF3 EPPK1 RPLP2 CUL9 RRBP1 EPB41L3 PGK1 AGO4 SUPT5H AHNAK SYNE2 BRD1 NOP2 GNL3 FLNA CAD TCOF1 TCP1 APOB MACROH2A1 TRIM28 ACIN1 MACF1 SNRPA | 5.52e-05 | 845 | 235 | 24 | int:CUL7 |
| Interaction | RPE interactions | 5.75e-05 | 58 | 235 | 6 | int:RPE | |
| Interaction | MYCN interactions | BRPF3 AGO2 RPLP2 VPS13C RCC1L NOP2 GNL3 HSPE1 FLNA CAD GNL3L EP400 TCOF1 TCP1 BICRA SMC4 YTHDC2 APOB MACROH2A1 HUWE1 KRR1 AGO1 ZC2HC1A TRIM28 UTP4 PUS1 ACIN1 NUMB TSPYL5 ATP12A SNRPA INO80B RAI1 | 6.07e-05 | 1373 | 235 | 33 | int:MYCN |
| Interaction | ESRRB interactions | RPLP2 ATAD5 RREB1 AHNAK ASCC3 MED17 ZNF687 GNL3L EP400 KANSL3 TIMM21 ATP2A3 | 6.23e-05 | 262 | 235 | 12 | int:ESRRB |
| Interaction | CBX3 interactions | BRPF3 ATAD5 SNRK RREB1 PGK1 CDCA2 SUPT5H KIF14 BRD1 HSPE1 EP400 TCOF1 NSD1 CHD8 MACROH2A1 RFX1 TRIM28 MACF1 SNCA TP53BP1 | 7.44e-05 | 646 | 235 | 20 | int:CBX3 |
| Interaction | FOLR1 interactions | AGO2 RPLP2 AHNAK KIF14 ALDOA FLNA TCOF1 TCP1 ISG15 SLC7A5 SNRPA | 7.63e-05 | 227 | 235 | 11 | int:FOLR1 |
| Interaction | TYROBP interactions | 7.63e-05 | 88 | 235 | 7 | int:TYROBP | |
| Interaction | AURKB interactions | XIRP1 EPPK1 MYO1A RPLP2 WNK1 AHNAK KIF14 BRD1 DNM1 NOP2 ILVBL FLNA DNAJC13 TCP1 RNF213 HEATR5A HUWE1 TIMM21 TRIM28 UTP4 MACF1 SLC7A5 | 8.84e-05 | 761 | 235 | 22 | int:AURKB |
| Interaction | NR2C2 interactions | SP2 RPLP2 PDLIM7 RRBP1 RREB1 EMSY RCC1L TOX4 AHNAK ASCC3 NOP2 ILVBL GNL3 ZNF687 DNM2 FLNA CAD SH3RF1 EP400 TCOF1 TCP1 SMC4 CHD8 MACROH2A1 HUWE1 KRR1 KANSL3 TRIM28 UTP4 PUS1 ACIN1 SNRPA TP53BP1 | 9.18e-05 | 1403 | 235 | 33 | int:NR2C2 |
| Interaction | H2AC4 interactions | PNKP EPPK1 ATAD5 GON4L SUPT5H KIF14 ZNF687 DNM2 FLNC EP400 CHD8 MACROH2A1 KRR1 TSPYL5 SNRPA TP53BP1 RAI1 | 9.87e-05 | 506 | 235 | 17 | int:H2AC4 |
| Interaction | EEF1AKMT3 interactions | NEIL2 VPS13C CUL9 WNK1 NAV1 ASCC3 ESPN TCP1 SMC4 ARHGEF12 HUWE1 ARMCX5 TBK1 HSPA14 | 1.02e-04 | 364 | 235 | 14 | int:EEF1AKMT3 |
| Interaction | FBXO2 interactions | ADAM23 ITGA6 PLXND1 ITGA5 NTM SYNE2 PLXNA3 FRAS1 DNAJC13 ECE1 EDIL3 ROBO1 SNCA SLAMF7 SORL1 | 1.03e-04 | 411 | 235 | 15 | int:FBXO2 |
| Interaction | MAP2K7 interactions | 1.10e-04 | 197 | 235 | 10 | int:MAP2K7 | |
| Interaction | TNRC6A interactions | AGO2 WNK1 AGO4 KIF14 MED17 TAP1 YTHDF2 AGO1 DCP1B TBK1 PAN3 TP53BP1 | 1.17e-04 | 280 | 235 | 12 | int:TNRC6A |
| Interaction | PPIA interactions | RPLP2 RRBP1 SUPT5H AHNAK KIF14 YTHDF2 ZNF687 HSPE1 FLNC EP400 TCP1 CHD8 HEATR5A HUWE1 KRR1 SKIL RFX1 KANSL3 ISG15 UTP4 NUMB MACF1 SNCA TP53BP1 | 1.18e-04 | 888 | 235 | 24 | int:PPIA |
| Interaction | CEBPA interactions | SP4 INPP5D SRP54 RREB1 PGK1 EMSY NFATC4 MED17 ALDOA NOP2 ZNF687 DNM2 FLNA EXOSC10 CAD EP400 TCP1 BICRA FOSL2 SMC4 CHD8 RFX1 KHDC4 KANSL3 ACIN1 MACF1 ELF1 SNRPA TP53BP1 RAI1 | 1.29e-04 | 1245 | 235 | 30 | int:CEBPA |
| Interaction | BAG2 interactions | BRPF3 VPS13C SRP54 RREB1 WNK1 MRTFB AHNAK KIF14 ASCC3 BRD1 NPAS1 DNAJC13 DNAJC16 DNAH2 HUWE1 RFX1 URGCP PHC1 ISG15 | 1.34e-04 | 622 | 235 | 19 | int:BAG2 |
| Interaction | TES interactions | PDLIM7 SRP54 ITGA5 BRD1 DNM2 FLNA FLNC CAD RDH12 HUWE1 TRIM28 MACF1 SLC7A5 | 1.51e-04 | 332 | 235 | 13 | int:TES |
| Interaction | UBE2O interactions | PNKP RPLP2 EMSY RCC1L KIF14 PLD1 MED17 GNL3 ZNF687 CAD GNL3L SHBG APOB HUWE1 KRR1 EDIL3 AGO1 TRIM28 ACIN1 NUMB MACF1 SLC7A5 | 1.51e-04 | 790 | 235 | 22 | int:UBE2O |
| Interaction | H2BC8 interactions | ATAD5 GON4L RREB1 CDCA2 SUPT5H BRD1 ZNF687 FOXM1 EXOSC10 GNL3L EP400 NSD1 CHD8 MACROH2A1 PHC1 ZNF711 ELF1 RAI1 | 1.53e-04 | 576 | 235 | 18 | int:H2BC8 |
| Interaction | TRIM66 interactions | 1.53e-04 | 205 | 235 | 10 | int:TRIM66 | |
| Interaction | TEDC2 interactions | 1.59e-04 | 206 | 235 | 10 | int:TEDC2 | |
| Interaction | PLEC interactions | PDLIM7 ITGA6 RRBP1 WNK1 SYDE2 AHNAK SYNE2 KIF14 FLNA DNAH3 SMC4 KRR1 URGCP ISG15 MACF1 | 1.69e-04 | 430 | 235 | 15 | int:PLEC |
| Interaction | ASF1A interactions | ATAD5 RREB1 EMSY CDCA2 ZNF687 EP400 BICRA NSD1 CHD8 PAN3 RAI1 | 1.73e-04 | 249 | 235 | 11 | int:ASF1A |
| Interaction | TRIM64 interactions | 1.77e-04 | 10 | 235 | 3 | int:TRIM64 | |
| Interaction | ITGB3 interactions | 1.77e-04 | 170 | 235 | 9 | int:ITGB3 | |
| Interaction | MEX3A interactions | EPPK1 TOX4 AHNAK NAV1 NOP2 YTHDF2 FLNA FOSL2 NSD1 CHD8 HUWE1 KHDC4 TRIM28 MACF1 | 1.77e-04 | 384 | 235 | 14 | int:MEX3A |
| Interaction | RANBP9 interactions | EPB41L3 WNK1 PIGR BRD1 ALDOA NOP2 GNL3 EXOSC10 ADAMTS1 MACROH2A1 HUWE1 KRR1 ARHGAP4 TRIM28 ACIN1 | 1.83e-04 | 433 | 235 | 15 | int:RANBP9 |
| Interaction | BAG5 interactions | RPLP2 PDLIM7 VPS13C AHNAK DNAJC13 TCP1 DNAJC16 RNF213 GBA2 WDR45 ISG15 P2RX6 SNCA | 1.96e-04 | 341 | 235 | 13 | int:BAG5 |
| Interaction | PHF21A interactions | RREB1 TOX4 MRTFB AHNAK NAV1 KIF14 ASCC3 ZNF687 FLNA DNAJC13 CHD8 HUWE1 TBK1 | 2.07e-04 | 343 | 235 | 13 | int:PHF21A |
| Interaction | MAP3K13 interactions | 2.13e-04 | 47 | 235 | 5 | int:MAP3K13 | |
| Interaction | AP2A1 interactions | AGO2 PDLIM7 KIF14 DNM1 DNM2 FLNA SGIP1 SHBG ISG15 TRIM28 ABCB11 NUMB | 2.15e-04 | 299 | 235 | 12 | int:AP2A1 |
| Interaction | BRD3 interactions | PNKP ATAD5 EPB41L3 KIF14 PLD1 TAF4B ZNF687 BICRA NSD1 CHD8 MACROH2A1 ZNF711 ACIN1 LTBP1 INO80B RAI1 | 2.39e-04 | 494 | 235 | 16 | int:BRD3 |
| Interaction | NFYC interactions | 2.40e-04 | 177 | 235 | 9 | int:NFYC | |
| Interaction | USP36 interactions | BRPF3 RPLP2 RRBP1 PIGR KIF14 MMP9 ALDOA NOP2 GNL3 FLNA EXOSC10 CAD TCP1 YTHDC2 MACROH2A1 KRR1 TRIM28 UTP4 | 2.47e-04 | 599 | 235 | 18 | int:USP36 |
| Interaction | TPRN interactions | 2.59e-04 | 49 | 235 | 5 | int:TPRN | |
| Interaction | CCDC8 interactions | EPPK1 CUL9 AHNAK ASCC3 NOP2 TAP1 FLNA CAD EP400 TCP1 SMC4 YTHDC2 APOB HUWE1 EDIL3 AGO1 TRIM28 TBK1 MACF1 | 2.64e-04 | 656 | 235 | 19 | int:CCDC8 |
| Interaction | TERF2IP interactions | ATAD5 RREB1 EMSY CDCA2 SUPT5H MED17 ZNF687 EP400 NSD1 CHD8 SCLY RFX1 PHC1 KANSL3 TRIM28 SNRPA RAI1 | 2.76e-04 | 552 | 235 | 17 | int:TERF2IP |
| Interaction | DCAF6 interactions | 2.81e-04 | 221 | 235 | 10 | int:DCAF6 | |
| Interaction | IFI16 interactions | AGO2 SUPT5H KIF14 ASCC3 BRD1 NOP2 GNL3 FLNA EXOSC10 TCP1 RNF213 YTHDC2 MACROH2A1 HUWE1 KRR1 RFX1 TRIM28 UTP4 ACIN1 TP53BP1 | 2.81e-04 | 714 | 235 | 20 | int:IFI16 |
| Interaction | DDX6 interactions | AGO2 RPLP2 PDLIM7 RRBP1 AGO4 KIF14 ASCC3 YTHDF2 GNL3 HUWE1 AGO1 DCP1B TRIM28 TSPYL5 PAN3 SNCA | 2.92e-04 | 503 | 235 | 16 | int:DDX6 |
| Interaction | PYHIN1 interactions | RREB1 PGK1 SUPT5H ZNF687 EXOSC10 GNL3L TCOF1 ADAMTS1 MACROH2A1 HUWE1 RFX1 ZNF711 RAI1 | 3.13e-04 | 358 | 235 | 13 | int:PYHIN1 |
| Interaction | PFN1 interactions | VPS13C WNK1 PGK1 SYNE2 NAV1 KIF14 DNM1 DNM2 HSPE1 DNAJC13 ARHGEF12 NBAS DCP1B ISG15 MACF1 TP53BP1 | 3.33e-04 | 509 | 235 | 16 | int:PFN1 |
| Interaction | ATOH1 interactions | 3.45e-04 | 80 | 235 | 6 | int:ATOH1 | |
| Interaction | SPDL1 interactions | EPPK1 RPLP2 PLXND1 WNK1 AHNAK FLNA FLNC CAD TCP1 SMC4 TRIM28 TP53BP1 | 3.46e-04 | 315 | 235 | 12 | int:SPDL1 |
| GeneFamily | Solute carriers | SLC26A4 SLC35G6 SLC7A11 SLC35G5 SLC23A2 SLC23A1 RHBG SLC13A2 SLC1A3 SLC1A6 SLC7A9 SLC7A8 SLC18A1 SLC25A39 SLC35G3 SLC7A5 | 5.01e-07 | 395 | 161 | 16 | 752 |
| GeneFamily | Argonaute/PIWI family | 3.76e-05 | 8 | 161 | 3 | 408 | |
| GeneFamily | ATP binding cassette subfamily B | 1.09e-04 | 11 | 161 | 3 | 806 | |
| GeneFamily | PWWP domain containing | 9.42e-04 | 22 | 161 | 3 | 1147 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.13e-03 | 8 | 161 | 2 | 939 | |
| GeneFamily | Regulatory factor X family | 2.13e-03 | 8 | 161 | 2 | 1153 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.13e-03 | 8 | 161 | 2 | 281 | |
| GeneFamily | PDZ domain containing | 2.42e-03 | 152 | 161 | 6 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.72e-03 | 9 | 161 | 2 | 755 | |
| GeneFamily | Plexins | 2.72e-03 | 9 | 161 | 2 | 683 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | SP4 GPRIN1 WNK1 NTM BRD1 BSN DNM2 MACROH2A1 SLC1A3 CACNG8 ACIN1 SETD7 | 4.64e-07 | 206 | 239 | 12 | M2817 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | SP4 GPRIN1 WNK1 NTM BRD1 BSN DNM2 MACROH2A1 SLC1A3 CACNG8 ACIN1 SETD7 | 5.15e-07 | 208 | 239 | 12 | MM581 |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP | ASCC3 MMP9 HS3ST3B1 SLC23A2 PLIN4 FOSL2 EDIL3 PHC1 POSTN PUS1 ATP12A | 2.35e-06 | 199 | 239 | 11 | M5105 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | IGSF6 AGO2 ADAM23 EPB41L3 PGK1 CDCA2 NAV1 KIF14 TAF4B CAMTA1 ASCC3 NOP2 FOXM1 HSPE1 COL6A3 FRAS1 CAD SGIP1 ANGPT2 SMC4 RNF213 SLC1A3 POSTN TIMM21 TBK1 PUS1 ROBO1 SLC7A5 SNRPA HSPA14 | 1.40e-05 | 1407 | 239 | 30 | M14427 |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.43e-05 | 197 | 239 | 10 | M8980 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.43e-05 | 197 | 239 | 10 | M8983 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.56e-05 | 199 | 239 | 10 | M9330 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 1.56e-05 | 199 | 239 | 10 | M7325 | |
| Coexpression | CHANDRAN_METASTASIS_UP | 2.38e-05 | 209 | 239 | 10 | M16036 | |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | 2.38e-05 | 209 | 239 | 10 | M2069 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SP2 MYO1A RPLP2 INPP5D CUL9 RREB1 SLC7A11 PGK1 TAF4B BRD1 NOP2 TAP1 NPAS1 FOXM1 EXOSC10 DNAJC13 CAD EP400 TCOF1 SCYL3 SMC4 MACROH2A1 KHDC4 ARHGAP4 CD40 ROBO1 ELF1 LY9 SNRPA | 3.08e-05 | 1394 | 239 | 29 | M9585 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ARMCX4 RRBP1 KCNA2 PIGR NAV1 SARDH VLDLR ADAMTS1 PHC1 POSTN ARHGAP4 ISG15 CD40 MACF1 ROBO1 LTBP1 TP53BP1 RAI1 SORL1 | 3.81e-05 | 721 | 239 | 19 | M1999 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | AGO2 ADAM23 ITGA6 SYNE2 KIF14 SLC23A2 ATMIN VLDLR FLNC DNAJC13 GPR143 SLC7A8 MLH3 ISG15 TBK1 ACIN1 NUMB MACF1 TSPYL5 SORL1 | 4.16e-05 | 790 | 239 | 20 | M12490 |
| Coexpression | ALK_DN.V1_UP | 4.75e-05 | 141 | 239 | 8 | M2774 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 5.14e-05 | 184 | 239 | 9 | M19988 | |
| Coexpression | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN | 5.21e-05 | 23 | 239 | 4 | M18912 | |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN | 9.04e-05 | 198 | 239 | 9 | M8173 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 9.39e-05 | 199 | 239 | 9 | M7319 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 9.76e-05 | 200 | 239 | 9 | M5973 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 1.05e-04 | 202 | 239 | 9 | M38982 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_44_PRECICTIVE_ICB_RESPONSE | 1.22e-04 | 206 | 239 | 9 | MM17084 | |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_DN | 1.32e-04 | 122 | 239 | 7 | M6866 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | ITGA6 GON4L SNRK SYNE2 TAF4B BRD1 KRR1 TMEM263 MLH3 UTP4 SNCA LY9 | 1.37e-04 | 363 | 239 | 12 | M41103 |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 1.49e-04 | 166 | 239 | 8 | M7722 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD | 1.54e-04 | 125 | 239 | 7 | M38988 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-08 | 193 | 239 | 10 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | ADAM23 EPB41L3 MRTFB SYNE2 TAF4B GNL3 ADAMTS1 KHDC4 POSTN ROBO1 | 1.04e-07 | 194 | 239 | 10 | 8dcde77767b23e75360adb316cdccf56a00e3726 |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-07 | 172 | 239 | 9 | 4790323a072cfe76127d704665a42c09601d84be | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-07 | 175 | 239 | 9 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-07 | 178 | 239 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 7.07e-07 | 184 | 239 | 9 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 185 | 239 | 9 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 185 | 239 | 9 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.23e-07 | 190 | 239 | 9 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.65e-07 | 191 | 239 | 9 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 193 | 239 | 9 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 193 | 239 | 9 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 193 | 239 | 9 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.10e-06 | 194 | 239 | 9 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 1.10e-06 | 194 | 239 | 9 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-06 | 194 | 239 | 9 | d790cfff3664e46fe2fd2f6b0c26896799927845 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.10e-06 | 194 | 239 | 9 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.10e-06 | 194 | 239 | 9 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 1.15e-06 | 195 | 239 | 9 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-06 | 196 | 239 | 9 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 197 | 239 | 9 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 197 | 239 | 9 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.30e-06 | 198 | 239 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.30e-06 | 198 | 239 | 9 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.30e-06 | 198 | 239 | 9 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 1.36e-06 | 199 | 239 | 9 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 200 | 239 | 9 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 200 | 239 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-06 | 200 | 239 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 200 | 239 | 9 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.41e-06 | 200 | 239 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 151 | 239 | 8 | 771224e0d6fccfa4225b3adccd7bc22a89a40793 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 151 | 239 | 8 | 5893a51585a65f1902cf85124a5ed9f02b4eb82a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-06 | 165 | 239 | 8 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-06 | 168 | 239 | 8 | 3611605114f6b668b44728d6563cd02389e106af | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | f38b52972a6c492ce2fd520a26bb3fc8db23bf85 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | 5320da1d61806b53e0bd96bbdfdb8fd69246681b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | e0076aa61b4ef3f836f5750005d0469d3982eb6d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | 2341eddfedaad8cee779c37bb87f7def058588ca | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | a5964aef04093b460bbe29d5e2e7389f8fd2d46f | |
| ToppCell | facs-Marrow-Granulocytes-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | 94871936ccfc73b56d425373b989b87c059d4493 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 171 | 239 | 8 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-06 | 171 | 239 | 8 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-06 | 173 | 239 | 8 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 6.01e-06 | 180 | 239 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-06 | 183 | 239 | 8 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 6.78e-06 | 183 | 239 | 8 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 183 | 239 | 8 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 184 | 239 | 8 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 184 | 239 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 184 | 239 | 8 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.06e-06 | 184 | 239 | 8 | 8880ff36c243cc60a524d74934d000aef26a70ac | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 7.06e-06 | 184 | 239 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.06e-06 | 184 | 239 | 8 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 7.34e-06 | 185 | 239 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 185 | 239 | 8 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 185 | 239 | 8 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 185 | 239 | 8 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 7.64e-06 | 186 | 239 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 187 | 239 | 8 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 187 | 239 | 8 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 7.94e-06 | 187 | 239 | 8 | 5429ae85942b8ec3895cceb63c663de3c24ca064 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 187 | 239 | 8 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 187 | 239 | 8 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 189 | 239 | 8 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.92e-06 | 136 | 239 | 7 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.92e-06 | 190 | 239 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-06 | 190 | 239 | 8 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.27e-06 | 191 | 239 | 8 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-06 | 192 | 239 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 1.00e-05 | 193 | 239 | 8 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.00e-05 | 193 | 239 | 8 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-05 | 193 | 239 | 8 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.04e-05 | 194 | 239 | 8 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.04e-05 | 194 | 239 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 197 | 239 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 197 | 239 | 8 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 197 | 239 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-05 | 197 | 239 | 8 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 239 | 8 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.16e-05 | 197 | 239 | 8 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 197 | 239 | 8 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 198 | 239 | 8 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 198 | 239 | 8 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 199 | 239 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class | 1.25e-05 | 199 | 239 | 8 | 90ddd686b8f39c6f6134b9b048396cebcf8d0448 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 1.25e-05 | 199 | 239 | 8 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 1.25e-05 | 199 | 239 | 8 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 1.25e-05 | 199 | 239 | 8 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-05 | 199 | 239 | 8 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.29e-05 | 200 | 239 | 8 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-05 | 200 | 239 | 8 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-05 | 200 | 239 | 8 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | ATAD5 VPS13C AHNAK SYNE2 SLC23A2 VLDLR EP400 DNAJC16 MFSD9 YTHDC2 SLC7A8 MACF1 SORL1 | 1.07e-07 | 191 | 236 | 13 | 4168_DN |
| Drug | AC1L1BXF | 2.46e-07 | 85 | 236 | 9 | CID000001650 | |
| Drug | sodium | SLC26A4 WNK1 SLC7A11 PGK2 KCNA2 NAV1 ABCC2 TAP1 SLC23A2 TAP2 SLC23A1 WNK4 GNL3 ADAMTS1 HUWE1 SLC13A2 SLC1A3 SLC1A6 PHC1 SLC7A9 SLC7A8 P2RX6 SLC18A1 TBK1 ABCB11 SLC7A5 ATP12A ATP2A3 | 6.05e-07 | 944 | 236 | 28 | CID000000923 |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | GON4L SLC7A11 BRD1 SLC23A2 WHRN GNL3L DNAJC16 ARHGEF12 MFSD9 SCLY GLCE ACIN1 | 1.03e-06 | 196 | 236 | 12 | 2119_DN |
| Drug | Mustard Gas | SP4 EPPK1 PDLIM7 ITGA6 ITGA5 CDCA2 NTM ACAN AHNAK KIF14 ALDH3A1 MMP9 ALDOA FOXM1 ESPN FLNC CRYBG2 FRAS1 ADAMTS1 RHBG SMC4 NSD1 SCLY HUWE1 SIM1 SLC1A3 SLC1A6 PHC1 SLC7A8 ISG15 CD40 SETD7 TP53BP1 | 3.51e-06 | 1341 | 236 | 33 | ctd:D009151 |
| Drug | NSC298883 | 4.06e-06 | 89 | 236 | 8 | CID000326807 | |
| Drug | NO-711 | 5.45e-06 | 66 | 236 | 7 | CID000004515 | |
| Drug | Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A | CUL9 SLC7A11 NTM AHNAK FLNA FLNC CRYBG2 APOB GRM1 ARHGAP4 LY9 | 5.83e-06 | 193 | 236 | 11 | 3348_UP |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SLC7A11 GK2 NTM GRM4 SLC7A8 P2RX6 TREM1 ABCB11 SNCA SLAMF7 PDZD2 | 7.44e-06 | 198 | 236 | 11 | 3928_UP |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | PDLIM7 SLC7A11 MRTFB DNM2 SLC1A3 GLCE CD40 SLC7A5 LY9 ATP2A3 INO80B | 7.44e-06 | 198 | 236 | 11 | 6183_DN |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | PDLIM7 GON4L CUL9 EMSY PLXNA3 SMC4 ECE1 SLC7A9 SLC7A8 MECR SORL1 | 7.81e-06 | 199 | 236 | 11 | 5570_DN |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HG-U133A | PECR SLC7A11 ACAN EP400 SMC4 NSD1 MLH3 MECR P2RX6 PUS1 INO80B | 7.81e-06 | 199 | 236 | 11 | 1915_UP |
| Drug | clorsulon | 1.08e-05 | 5 | 236 | 3 | CID000043231 | |
| Drug | eicosane | 1.60e-05 | 107 | 236 | 8 | CID000008222 | |
| Drug | dibromosulphthalein | 2.15e-05 | 6 | 236 | 3 | CID000086995 | |
| Drug | 2-phenylglycine | 2.21e-05 | 55 | 236 | 6 | CID000003866 | |
| Drug | ribulose-1,5-bisphosphate | 2.31e-05 | 82 | 236 | 7 | CID000001192 | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | SLC7A11 TOX4 NPAS1 GPR143 HUWE1 GRM1 ECE1 SLC13A2 SNCA ATP2A3 | 3.23e-05 | 191 | 236 | 10 | 7486_UP |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.53e-05 | 193 | 236 | 10 | 6209_UP | |
| Drug | 3,5-dihydroxyphenylglycine | 3.65e-05 | 60 | 236 | 6 | CID000108001 | |
| Drug | Avermectin B1 [71751-41-2]; Up 200; 4.8uM; MCF7; HT_HG-U133A | SLC7A11 NTM PLD1 ALDH3A1 VLDLR COL6A3 GPR143 IL36RN TREM1 ATP12A | 3.69e-05 | 194 | 236 | 10 | 6081_UP |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 3.69e-05 | 194 | 236 | 10 | 263_UP | |
| Drug | benzyloxyaspartate | 3.81e-05 | 37 | 236 | 5 | CID004133412 | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | ATAD5 PDLIM7 PLXNA3 DNAH3 SLC7A9 ARHGAP4 NOX1 CD40 LTBP1 INO80B | 3.85e-05 | 195 | 236 | 10 | 1501_DN |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | PLD1 FLNC CRYBG2 DNAJC16 SLC7A9 KANSL3 SLC7A8 POSTN ARHGAP4 ATP2A3 | 3.85e-05 | 195 | 236 | 10 | 2897_UP |
| Drug | AC1L2YVP | 3.86e-05 | 19 | 236 | 4 | CID000080135 | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | ADAM23 MATN1 EML2 PLXND1 GRM1 SLC1A6 LIPE TREM1 SLAMF7 ATP2A3 | 4.20e-05 | 197 | 236 | 10 | 3686_UP |
| Drug | 5707885; Down 200; 50uM; MCF7; HT_HG-U133A | 4.20e-05 | 197 | 236 | 10 | 6385_DN | |
| Drug | aldonates | 4.23e-05 | 90 | 236 | 7 | CID000000752 | |
| Drug | 4CPG | 4.35e-05 | 38 | 236 | 5 | CID000005115 | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | MATN1 INPP5D PLXND1 GK2 PIGR ACAN SLC23A2 BICRA DNAH2 ATP2A3 | 4.38e-05 | 198 | 236 | 10 | 3722_UP |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | PECR EPPK1 ITGA6 DNM1 SLC23A2 EP400 MACROH2A1 NUMB ROBO1 ELF1 | 4.38e-05 | 198 | 236 | 10 | 6250_DN |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 4.57e-05 | 199 | 236 | 10 | 5264_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | MYO1A NFATC4 ACAN FLNC DNAJC16 HUWE1 ECE1 SLC7A9 IL36RN SNCA | 4.57e-05 | 199 | 236 | 10 | 3603_UP |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; HL60; HT_HG-U133A | BICRA FOSL2 ARHGEF12 SCLY GRM4 SLC7A8 NOX1 LTBP1 ATP2A3 INO80B | 4.57e-05 | 199 | 236 | 10 | 3096_UP |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 4.77e-05 | 200 | 236 | 10 | 643_UP | |
| Drug | 4-amino-2,6-dinitrotoluene | WNK1 RCC1L BRD1 BSN ALDOA CAD GNL3L EP400 TCP1 RHBG MACROH2A1 SCLY MLH3 TRIM28 UTP4 PUS1 SNRPA | 5.39e-05 | 541 | 236 | 17 | ctd:C035207 |
| Drug | calcein AM | 5.93e-05 | 8 | 236 | 3 | ctd:C085925 | |
| Drug | vinylidene chloride | PECR IGSF6 ATAD5 PDLIM7 SLC26A4 ITGA5 EPB41L3 MRTFB PIGR AHNAK NAV3 PLD1 HS3ST3B1 SLC23A1 GNL3 FOXM1 FLNA ADAMTS1 RHBG FOSL2 SMC4 NSD1 MFSD9 PCDHA11 SIM1 SLC7A8 POSTN NLRP10 MECR SLC18A1 TSPYL5 SLC7A5 | 6.04e-05 | 1475 | 236 | 32 | ctd:C029297 |
| Drug | p-Nitrophenyl alpha-D-xyloside | 6.34e-05 | 41 | 236 | 5 | CID000082482 | |
| Drug | AC1L1FET | 7.11e-05 | 22 | 236 | 4 | CID000003205 | |
| Drug | dihydroxyacetone | 7.31e-05 | 98 | 236 | 7 | CID000000670 | |
| Drug | Rh(H2O)4ATP | 8.82e-05 | 9 | 236 | 3 | CID003082848 | |
| Drug | arabinopyranose | PGK2 ACAN ALDOA ALDOB GNL3 HSPE1 COL6A3 GBA2 ABCC6 POSTN GLCE | 9.42e-05 | 261 | 236 | 11 | CID000000229 |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 1.07e-04 | 2 | 236 | 2 | CID000135804 | |
| Drug | midecamycin | 1.07e-04 | 2 | 236 | 2 | ctd:C026483 | |
| Drug | 6-deoxy-6-bromoascorbic acid | 1.07e-04 | 2 | 236 | 2 | ctd:C068572 | |
| Drug | bromfenac | 1.07e-04 | 2 | 236 | 2 | ctd:C053083 | |
| Drug | Dpgyigsr | 1.07e-04 | 2 | 236 | 2 | CID000131133 | |
| Drug | AC1L1CUI | 1.11e-04 | 46 | 236 | 5 | CID000002069 | |
| Drug | DL-valine | 1.13e-04 | 105 | 236 | 7 | CID000001182 | |
| Drug | tartronate semialdehyde | 1.25e-04 | 10 | 236 | 3 | CID000001122 | |
| Drug | Demecolcine | EPPK1 AGO2 GON4L TOGARAM1 WNK1 SLC7A11 CDCA2 RCC1L AHNAK SYNE2 MED17 TAP1 GNL3L MUC19 YTHDC2 SCLY SKIL ISG15 CD40 NUMB SLAMF7 HSPA14 | 1.29e-04 | 878 | 236 | 22 | ctd:D003703 |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.29e-04 | 183 | 236 | 9 | 7062_DN | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.35e-04 | 184 | 236 | 9 | 5228_UP | |
| Drug | hilE | 1.39e-04 | 76 | 236 | 6 | CID000000791 | |
| Drug | AC1NDZBW | 1.52e-04 | 187 | 236 | 9 | CID004634040 | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A | 1.52e-04 | 187 | 236 | 9 | 2017_UP | |
| Drug | AC1L1A5Z | 1.60e-04 | 111 | 236 | 7 | CID000000850 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.65e-04 | 189 | 236 | 9 | 1168_DN | |
| Drug | diethylcarbitol | 1.71e-04 | 11 | 236 | 3 | CID000008179 | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.78e-04 | 191 | 236 | 9 | 4303_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 191 | 236 | 9 | 2634_DN | |
| Drug | sulfate | PNKP SPAM1 SLC26A4 SRP54 WNK1 PGK2 EMSY ACAN ABCC2 MED17 HS3ST3B1 ALDOA HSPE1 COL6A3 SHBG APOB SCLY GRM1 SLC13A2 GBA2 POSTN ARHGAP4 IL36RN MECR GLCE TREM1 ABCB11 SNRPA | 1.84e-04 | 1292 | 236 | 28 | CID000001117 |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 236 | 9 | 7004_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 236 | 9 | 6512_UP | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; HL60; HT_HG-U133A | 1.86e-04 | 192 | 236 | 9 | 1847_DN | |
| Drug | mono-(2-ethylhexyl)phthalate | ADAM23 EPB41L3 SLC7A11 PLD1 ABCC2 ASCC3 MMP9 PLIN4 VLDLR SH3RF1 BICRA ABCC6 SLC7A9 LIPE CD40 ELF1 LTBP1 ATP12A | 1.87e-04 | 658 | 236 | 18 | ctd:C016599 |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.93e-04 | 193 | 236 | 9 | 6789_UP | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.93e-04 | 193 | 236 | 9 | 4174_UP | |
| Drug | Podophyllotoxin [518-28-5]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.93e-04 | 193 | 236 | 9 | 2540_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | KIAA0586 RRBP1 WNK1 SLC23A2 GNL3L EP400 DNAJC16 MACF1 TP53BP1 | 2.01e-04 | 194 | 236 | 9 | 1670_DN |
| Drug | butein; Up 200; 10uM; MCF7; HG-U133A | 2.01e-04 | 194 | 236 | 9 | 607_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 4738_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 5056_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 6201_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 3194_DN | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.01e-04 | 194 | 236 | 9 | 2825_UP | |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 2.08e-04 | 195 | 236 | 9 | 333_DN | |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A | 2.08e-04 | 195 | 236 | 9 | 2861_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 2961_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A | 2.16e-04 | 196 | 236 | 9 | 203_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 3692_UP | |
| Drug | Vinpocetine [42971-09-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 7213_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 5088_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 2.16e-04 | 196 | 236 | 9 | 2800_UP | |
| Drug | NSC49633 | 2.19e-04 | 53 | 236 | 5 | CID000023340 | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 5796_UP | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; PC3; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 4069_UP | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 4394_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 7401_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; PC3; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 6284_UP | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; HL60; HG-U133A | 2.25e-04 | 197 | 236 | 9 | 1401_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 6059_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; HL60; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 2492_DN | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A | 2.25e-04 | 197 | 236 | 9 | 2380_UP | |
| Drug | Go7874 | 2.26e-04 | 12 | 236 | 3 | CID005327863 | |
| Drug | sodium 4-phenylbutyrate; Down 200; 200uM; SKMEL5; HG-U133A | 2.33e-04 | 198 | 236 | 9 | 502_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 2943_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.33e-04 | 198 | 236 | 9 | 5479_UP | |
| Disease | Malignant neoplasm of breast | XIRP1 RPLP2 PDLIM7 EPB41L3 WNK1 EMSY SYNE2 MMP9 ALDOA FOXM1 FLNA ADAMTS1 TCP1 MFSD9 SIM1 PPP1R3A LIPE CD40 TREM1 PUS1 MACF1 ROBO1 ATP2A3 HSPA14 TP53BP1 SORL1 | 4.90e-07 | 1074 | 234 | 26 | C0006142 |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 4.87e-06 | 5 | 234 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 4.87e-06 | 5 | 234 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 4.87e-06 | 5 | 234 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | rhabdomyosarcoma (biomarker_via_orthology) | 6.26e-05 | 2 | 234 | 2 | DOID:3247 (biomarker_via_orthology) | |
| Disease | T-lymphocyte surface antigen Ly-9 measurement | 6.26e-05 | 2 | 234 | 2 | EFO_0008295 | |
| Disease | alkaline phosphatase measurement | NEIL2 MATN1 SLC26A4 RRBP1 RREB1 NFATC4 AHNAK MMP9 ALDOB WHRN DNAJC13 APOB ECE1 SLC1A3 TMEM263 ABCB11 MACF1 ELF1 SNRPA TP53BP1 RAI1 | 6.53e-05 | 1015 | 234 | 21 | EFO_0004533 |
| Disease | visceral adipose tissue measurement, body mass index | 6.89e-05 | 87 | 234 | 6 | EFO_0004340, EFO_0004765 | |
| Disease | collagen disease (implicated_via_orthology) | 1.03e-04 | 12 | 234 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 1.03e-04 | 12 | 234 | 3 | DOID:1312 (biomarker_via_orthology) | |
| Disease | waist-hip ratio | ADAM23 CUL9 PLXND1 RREB1 WNK1 CDCA2 AHNAK SYNE2 NAV3 PLD1 GNL3 PLIN4 SHBG NSD1 YTHDC2 SIM1 RFX7 ECE1 PHC1 PPP1R3A DCP1B DNM3 ROBO1 | 1.27e-04 | 1226 | 234 | 23 | EFO_0004343 |
| Disease | Profound Mental Retardation | 1.27e-04 | 139 | 234 | 7 | C0020796 | |
| Disease | Mental deficiency | 1.27e-04 | 139 | 234 | 7 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.27e-04 | 139 | 234 | 7 | C0025363 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.33e-04 | 13 | 234 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | EML2 WNK1 ABCC2 FLNC DNAH3 CAD TCOF1 APOB GRM1 ABCC6 POSTN MLH3 TRIM28 ABCB11 ACIN1 SORL1 | 1.69e-04 | 702 | 234 | 16 | C0009402 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.87e-04 | 3 | 234 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | MHC class I deficiency (is_implicated_in) | 1.87e-04 | 3 | 234 | 2 | DOID:0060009 (is_implicated_in) | |
| Disease | X-24431 measurement | 1.87e-04 | 3 | 234 | 2 | EFO_0800882 | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.87e-04 | 3 | 234 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 2.07e-04 | 37 | 234 | 4 | DOID:0050865 (is_marker_for) | |
| Disease | Schizophrenia | SP4 NAV1 ALDH3A1 MMP9 BRD1 DNM1 TAP1 TAP2 NPAS1 VLDLR GRM1 GRM4 SLC1A3 SLC1A6 CACNG8 SLC18A1 TREM1 RAI1 | 2.62e-04 | 883 | 234 | 18 | C0036341 |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.82e-04 | 40 | 234 | 4 | EFO_0004746 | |
| Disease | dermatomyositis (is_marker_for) | 3.08e-04 | 17 | 234 | 3 | DOID:10223 (is_marker_for) | |
| Disease | response to radiation, Urinary retention | 3.08e-04 | 17 | 234 | 3 | GO_0009314, HP_0000016 | |
| Disease | epilepsy (implicated_via_orthology) | 3.37e-04 | 163 | 234 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Bare Lymphocyte Syndrome, Type I | 3.72e-04 | 4 | 234 | 2 | C1858266 | |
| Disease | tartronate (hydroxymalonate) measurement | 3.72e-04 | 4 | 234 | 2 | EFO_0800944 | |
| Disease | MHC class I deficiency | 3.72e-04 | 4 | 234 | 2 | cv:C1858266 | |
| Disease | tuberous sclerosis (is_marker_for) | 3.72e-04 | 4 | 234 | 2 | DOID:13515 (is_marker_for) | |
| Disease | Pseudohypoaldosteronism type 2A | 3.72e-04 | 4 | 234 | 2 | cv:C1840389 | |
| Disease | Pseudohypoaldosteronism, type 2 | 3.72e-04 | 4 | 234 | 2 | cv:C1449844 | |
| Disease | epilepsy (is_marker_for) | 3.72e-04 | 4 | 234 | 2 | DOID:1826 (is_marker_for) | |
| Disease | creatinine measurement | RREB1 EPB41L3 CFAP70 ASCC3 BSN ALDOB SLC23A2 SLC23A1 PLIN4 DNAJC13 DNAJC16 NSD1 SCLY SIM1 SLC1A3 SLC7A9 PPP1R3A NUMB SORL1 | 3.99e-04 | 995 | 234 | 19 | EFO_0004518 |
| Disease | hypertension (is_implicated_in) | 4.20e-04 | 121 | 234 | 6 | DOID:10763 (is_implicated_in) | |
| Disease | urate measurement, bone density | TOX4 NTM NAV1 KIF14 TAF4B SLC23A2 SLC23A1 FRAS1 SIM1 SLC7A8 TREM1 ROBO1 SH3RF3 PDZD2 | 4.63e-04 | 619 | 234 | 14 | EFO_0003923, EFO_0004531 |
| Disease | Epilepsy, Cryptogenic | 4.99e-04 | 82 | 234 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 4.99e-04 | 82 | 234 | 5 | C0751111 | |
| Disease | Aura | 4.99e-04 | 82 | 234 | 5 | C0236018 | |
| Disease | myopathy (implicated_via_orthology) | 5.70e-04 | 48 | 234 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 6.16e-04 | 5 | 234 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | reactive arthritis (is_implicated_in) | 6.16e-04 | 5 | 234 | 2 | DOID:6196 (is_implicated_in) | |
| Disease | Neoplasm Invasiveness | 6.95e-04 | 184 | 234 | 7 | C0027626 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 8.81e-04 | 24 | 234 | 3 | DOID:1184 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 8.93e-04 | 54 | 234 | 4 | DOID:6432 (implicated_via_orthology) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 9.20e-04 | 6 | 234 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | amphetamine abuse (implicated_via_orthology) | 9.20e-04 | 6 | 234 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | extraversion measurement | 9.20e-04 | 6 | 234 | 2 | EFO_0007913 | |
| Disease | chorioamnionitis (is_marker_for) | 9.20e-04 | 6 | 234 | 2 | DOID:0050697 (is_marker_for) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 9.20e-04 | 6 | 234 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 9.51e-04 | 447 | 234 | 11 | C3714756 | |
| Disease | urate measurement, spine bone mineral density | 1.17e-03 | 58 | 234 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 1.28e-03 | 7 | 234 | 2 | EFO_0800551 | |
| Disease | arteriosclerosis (implicated_via_orthology) | 1.28e-03 | 7 | 234 | 2 | DOID:2349 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in IDL percentage | 1.33e-03 | 60 | 234 | 4 | EFO_0022233 | |
| Disease | interleukin 5 measurement | 1.39e-03 | 28 | 234 | 3 | EFO_0008185 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.40e-03 | 103 | 234 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | hair morphology | 1.54e-03 | 29 | 234 | 3 | EFO_0005038 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.63e-03 | 157 | 234 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | Cholestasis of pregnancy | 1.70e-03 | 8 | 234 | 2 | C0268318 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 1.70e-03 | 8 | 234 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | Epileptic encephalopathy | 1.71e-03 | 30 | 234 | 3 | C0543888 | |
| Disease | Epilepsy | 1.80e-03 | 109 | 234 | 5 | C0014544 | |
| Disease | Cholestasis | 1.87e-03 | 110 | 234 | 5 | C0008370 | |
| Disease | arteriosclerosis (is_implicated_in) | 1.88e-03 | 31 | 234 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | Grand Mal Status Epilepticus | 2.00e-03 | 67 | 234 | 4 | C0311335 | |
| Disease | Petit mal status | 2.00e-03 | 67 | 234 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.00e-03 | 67 | 234 | 4 | C0393734 | |
| Disease | Status Epilepticus, Subclinical | 2.00e-03 | 67 | 234 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.00e-03 | 67 | 234 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.00e-03 | 67 | 234 | 4 | C0751523 | |
| Disease | neuroticism measurement, cognitive function measurement | AGO2 EML2 TTBK1 NAV1 ASCC3 PCDHA11 PCDHA10 SIM1 ECE1 CDH19 DNM3 RAI1 | 2.00e-03 | 566 | 234 | 12 | EFO_0007660, EFO_0008354 |
| Disease | atrial fibrillation (is_marker_for) | 2.06e-03 | 32 | 234 | 3 | DOID:0060224 (is_marker_for) | |
| Disease | Status Epilepticus | 2.11e-03 | 68 | 234 | 4 | C0038220 | |
| Disease | lung cancer (implicated_via_orthology) | 2.17e-03 | 9 | 234 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | bacterial pneumonia (is_marker_for) | 2.17e-03 | 9 | 234 | 2 | DOID:874 (is_marker_for) | |
| Disease | cholestasis (implicated_via_orthology) | 2.17e-03 | 9 | 234 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | synaptotagmin-11 measurement | 2.17e-03 | 9 | 234 | 2 | EFO_0802108 | |
| Disease | myocardial infarction (is_marker_for) | 2.25e-03 | 33 | 234 | 3 | DOID:5844 (is_marker_for) | |
| Disease | psoriasis (is_implicated_in) | 2.46e-03 | 34 | 234 | 3 | DOID:8893 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | AGO2 MYO1A WNK1 CDCA2 SYNE2 PLD1 SLC23A2 SLC23A1 GNL3 DNM2 AQP10 DNAJC13 EP400 SHBG APOB ECE1 GBA2 SLC7A8 PUS1 ABCB11 SLC7A5 | 2.57e-03 | 1347 | 234 | 21 | EFO_0005192 |
| Disease | body weight | ATAD5 VPS13C GON4L PGK1 TOX4 NFATC4 ACAN SH3RF1 ARHGEF12 CHD8 HUWE1 SIM1 ECE1 CDH19 PPP1R3A NBAS ZC2HC1A DNM3 LTBP1 PDZD2 | 2.66e-03 | 1261 | 234 | 20 | EFO_0004338 |
| Disease | abdominal aortic aneurysm (is_marker_for) | 2.70e-03 | 10 | 234 | 2 | DOID:7693 (is_marker_for) | |
| Disease | N6-acetyllysine measurement | 2.70e-03 | 10 | 234 | 2 | EFO_0800036 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.70e-03 | 10 | 234 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.70e-03 | 10 | 234 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.70e-03 | 10 | 234 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.70e-03 | 10 | 234 | 2 | C1449842 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.70e-03 | 10 | 234 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Pseudohypoaldosteronism, Type I | 2.70e-03 | 10 | 234 | 2 | C0268436 | |
| Disease | threonate measurement | 2.70e-03 | 10 | 234 | 2 | EFO_0021032 | |
| Disease | Pseudohypoaldosteronism | 2.70e-03 | 10 | 234 | 2 | C0033805 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.83e-03 | 121 | 234 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.87e-03 | 74 | 234 | 4 | DOID:3748 (is_marker_for) | |
| Disease | neutrophil measurement | 2.97e-03 | 177 | 234 | 6 | EFO_0803548 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 3.04e-03 | 123 | 234 | 5 | EFO_0007789, EFO_0008002 | |
| Disease | hematocrit | BRPF3 RREB1 BSN VLDLR DNAJC13 DNAJC16 DNAH2 APOB SIM1 ABCC6 TBK1 DNM3 NUMB SLC7A5 SNRPA TP53BP1 RAI1 | 3.07e-03 | 1011 | 234 | 17 | EFO_0004348 |
| Disease | mean corpuscular hemoglobin concentration | AGO2 GON4L RREB1 AGO4 MED17 SLC23A2 SLC23A1 ATMIN DNAJC13 EP400 ECE1 TBK1 PUS1 ABCB11 MACF1 SLC7A5 ELF1 PAN3 | 3.27e-03 | 1105 | 234 | 18 | EFO_0004528 |
| Disease | degenerative disc disease (biomarker_via_orthology) | 3.29e-03 | 11 | 234 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | polymyositis (is_marker_for) | 3.29e-03 | 11 | 234 | 2 | DOID:0080745 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFKSVIAQIGPGGTI | 281 | Q8NAT2 | |
| LVVTKGFSGTPGSNE | 131 | Q9NP99 | |
| VVSATKGVPAGNSDT | 826 | Q9UKV3 | |
| NTVLITGPTGVGKTA | 1126 | Q96QE3 | |
| GKDGQTGTPVAIATQ | 451 | Q96L91 | |
| PVKELTGGGTTFSVR | 366 | O95696 | |
| PEGLTQTVKGASAVA | 196 | P46092 | |
| TAQPLVAGTANGGKV | 186 | Q9HCK8 | |
| NGGKVTFTKVLTGTP | 196 | Q9HCK8 | |
| SIVSGNTVLAAKVPG | 216 | Q9HCK8 | |
| STVQVTGNPKGTSVG | 1331 | Q9Y6Y1 | |
| VSSSPGVKGGATTVL | 331 | P32519 | |
| GVKGGATTVLKPGNS | 336 | P32519 | |
| KGPSATNLIIGSIAG | 786 | O75077 | |
| QGGAPLAGTNKETTI | 111 | P05062 | |
| VGAIAAGNSVVLKPS | 126 | P30838 | |
| KGVVPLAGTNGETTT | 111 | P04075 | |
| KPERVVGVIGASGSS | 146 | Q14833 | |
| KGVTIASGGVLPNIH | 96 | O75367 | |
| RIGKSGNIPAGTTVD | 721 | Q9UL18 | |
| LTGTAGKISSISQPG | 406 | O15123 | |
| GGNLTVTGPKETASI | 131 | Q96PS8 | |
| VLQATVVAVGSGSKG | 41 | P61604 | |
| SGSKGKGGEIQPVSV | 51 | P61604 | |
| LVGSVGAAVNGTVTP | 756 | O95342 | |
| QEAQGGVSGSLKGVP | 431 | Q9ULD4 | |
| GGVQVPAVDISSSLG | 271 | Q09666 | |
| PVVGGFNSNVGSKVL | 86 | O94923 | |
| GQPVLLAGEAATGKS | 2381 | Q96M86 | |
| VGKSGNVPAGTTVDS | 726 | Q9HCK5 | |
| LKVGAGEGTTDSAQP | 616 | Q5H9R4 | |
| NTIAVPKAGTGAGTR | 1011 | Q5H9R4 | |
| GISGPATARVNGKTQ | 21 | Q6P1M9 | |
| GTNITSGKAVGVAVA | 211 | Q93084 | |
| NERVGKSGNIPAGTT | 721 | Q9UKV8 | |
| GSKQVGETSAPGDTL | 686 | Q9NZN5 | |
| AQVGKATVASGISPG | 296 | P07205 | |
| PLVRTGVAGASSGVA | 111 | Q6ZS82 | |
| SSPTKLGGDLAGVNV | 271 | Q96I51 | |
| GLVNVGTGQKLPTSG | 1381 | Q7Z5J4 | |
| TNSPVGVSKVLVSGG | 946 | Q96L73 | |
| VVGASGVGKSALTIQ | 46 | Q7Z444 | |
| LQGVGQPTGTGSIRK | 236 | Q9UHI8 | |
| QSVATVAGSGKSPGE | 381 | Q99742 | |
| SGIFVSPKGVLENAG | 56 | Q9UHI5 | |
| SPKGVLENAGSVGLA | 61 | Q9UHI5 | |
| VGAGIGVTPFASILK | 401 | Q9Y5S8 | |
| QLPGKVVVITGANTG | 36 | Q96NR8 | |
| SLGKGVVVPTRFGNA | 211 | P14780 | |
| SAGGAVNKLVPRSVG | 571 | Q9Y5I1 | |
| TIKNFGGTVSIIPVG | 851 | Q15058 | |
| TSVSLPAIGTGNAGK | 401 | Q460N3 | |
| VPTTIGGKIVGSLCA | 381 | P16389 | |
| VSPGGSTSVGLQVVV | 1606 | Q86XX4 | |
| GSGSKQLPQAIIIGV | 131 | Q9Y662 | |
| FTVSSGARPGAQKVG | 366 | P21941 | |
| PFVGQQVVKTGGSSK | 16 | Q969S2 | |
| VKSLGASPTVAGIVG | 71 | Q8NBP5 | |
| SEAKGTGVPVGQKGT | 226 | Q9P121 | |
| PSLVVLQGSAGTGKT | 166 | Q86W26 | |
| SVAVKVVQGPAGGDN | 1011 | Q9UBC5 | |
| LPQIAVVGGQSAGKS | 31 | Q05193 | |
| ASLASGVGNEKTPIA | 286 | P54707 | |
| ASQGLGPGSTVLLVV | 61 | P05161 | |
| GAGKQKTAVSGLTPG | 4166 | Q2LD37 | |
| SKGLTTVFSGIGQPA | 671 | B1AK53 | |
| AKSATAVPAGLGATE | 326 | Q9UPA5 | |
| LPQIAVVGGQSAGKS | 31 | Q9UQ16 | |
| VEQGQGPSKLFVGTA | 156 | P51805 | |
| GPLSGVVTVNASKEG | 956 | Q9Y4D7 | |
| SGIFVTPTGVLKEAG | 66 | Q8MH63 | |
| SKVPQETQSGGGSRL | 141 | Q14766 | |
| TTGGIQGTLPLTVQK | 1341 | Q9UHC1 | |
| GTTGKSFIESGPSVV | 2271 | Q7Z5P9 | |
| GVTGTIKPSVAGSVT | 2971 | Q7Z5P9 | |
| GTTGPSAVVTGKTEL | 5411 | Q7Z5P9 | |
| PGKQAGTSGVSLATT | 7231 | Q7Z5P9 | |
| KTAGITAAPGKQAGT | 7671 | Q7Z5P9 | |
| KQAGTSGVAPGTTVA | 7681 | Q7Z5P9 | |
| ATSVKVTVAGFQPGG | 1161 | O15018 | |
| GGSIVNIIVPTKAGF | 151 | Q9BY49 | |
| QGGAPSRQKAGTSAL | 996 | Q8IVL0 | |
| HSLAQIGGKSPVAGV | 191 | Q7L5A3 | |
| VGTLGFSIEGPSQAK | 601 | Q14315 | |
| GQPVSTGGQTLVAKK | 651 | Q9ULH7 | |
| GAHSTPSILGIINGK | 211 | Q9Y2G8 | |
| SGIFVTPTGVLKEAG | 66 | Q01650 | |
| QGNTVSAIGPFSGLK | 186 | Q13601 | |
| LVAVIGPVGSGKSSL | 666 | Q92887 | |
| SGIFVTPTGVLKEAG | 66 | Q9GIP4 | |
| GLGPIESIGNASAIT | 556 | Q9NVC6 | |
| GVTVQSQGPGGKVVT | 116 | P23229 | |
| AKTGQATVASGIPAG | 296 | P00558 | |
| PVKVTALGGGNLEAT | 51 | Q9NY56 | |
| KLASVPAGGAVAVSA | 61 | P05387 | |
| LPQIAVVGGQSAGKS | 31 | P50570 | |
| NSVKSVPVSAGGEGE | 3406 | Q7Z6Z7 | |
| VTNGGDGVTAVPKTL | 286 | A2RRP1 | |
| SRLTPGGKAAQAGVA | 31 | Q9NR12 | |
| VLVSGEPGSGKSTQI | 66 | Q8TE96 | |
| DASLSPVILGVQGGS | 51 | Q9UBH0 | |
| QGKTGSILPSVGSSV | 4406 | Q9UPN3 | |
| GKVSTAGDISGATPV | 2071 | P16112 | |
| GGQVLGTKSVPTFTV | 76 | Q9C086 | |
| GSQAPKASSRASVGV | 671 | Q9Y5I2 | |
| GNPKISVAGIGASNR | 546 | Q16821 | |
| SSLDTKVNPGGGITA | 576 | Q8IZE3 | |
| GGITATKPVTSGEQK | 586 | Q8IZE3 | |
| TPSSGQVIQKETVGG | 386 | Q58A45 | |
| TDGVSVLVGAPKANT | 71 | P08648 | |
| LKAHQGTGAGISPVI | 136 | Q8IZD4 | |
| VTGVITQGAKRIGSP | 226 | O43854 | |
| GSVVAVTKASGGLPQ | 41 | Q01780 | |
| LQISSSGVIAPGAKA | 846 | P04114 | |
| AGEPISTGVQVNFGK | 376 | O43313 | |
| AFPKEAGGGVTVTVT | 371 | Q8WXS5 | |
| PEARAKQTGGGTTLV | 126 | O95976 | |
| AVKLPGGQLSSTVAA | 1761 | Q86XA9 | |
| GVAAVTAGPGLTNTV | 116 | A1L0T0 | |
| TAAVGPLVGAVVQGT | 6 | Q14410 | |
| LFVGPTGTGKSAITN | 2071 | Q8TD57 | |
| TGQSTPTQKGVGIAG | 376 | Q9HCG7 | |
| QGKGNVDGVAATPTA | 11 | Q9H2C2 | |
| KSQGDASKVTAQGPG | 376 | P21333 | |
| VGTLGFSVEGPSQAK | 606 | P21333 | |
| QGKVASKIVGPSGAA | 1001 | P21333 | |
| SKVKASGPGLNTTGV | 1546 | P21333 | |
| GITNGSATAIKVEAP | 801 | Q5T0N1 | |
| VGGKPTLQKQGTISS | 1121 | Q5JV73 | |
| ASIGAAGIPQAGLVT | 436 | P43003 | |
| GTIIGSGIFVSPKSV | 41 | P82251 | |
| PASGKVSQVGGQTSD | 351 | P51810 | |
| TKAAGSRAGDGVPQV | 131 | P12111 | |
| GPKGSSSIQKEAVQG | 636 | Q8N1P7 | |
| TVPATTVKIVSLGGG | 1146 | Q3T8J9 | |
| SGGGSVGAVVVKQEP | 211 | P15408 | |
| ASVGAAGIPQAGLVT | 461 | P48664 | |
| SISPVGKGQGTEFNL | 56 | O75165 | |
| SGKDSAPTVVSGILG | 46 | Q9HBG7 | |
| GNASFILGTGKIVTP | 21 | Q69YH5 | |
| KVGGLDFSPVQTSQG | 631 | Q08050 | |
| RVGVIGFPNVGKSSI | 256 | Q9BVP2 | |
| IKVSLISQGDTAGGP | 646 | Q9P2N6 | |
| IITNGVVKAATGTSP | 181 | Q7Z7F0 | |
| VEKGAGATVLGTAFP | 451 | Q8IWT3 | |
| TGVTVNGGIPQKISL | 106 | P38567 | |
| QVVAVGSNVTGLKPG | 111 | Q9BV79 | |
| AGGEKTIQTVPTGAK | 606 | Q7Z589 | |
| ATGQVAGTTKEGKPL | 121 | O95834 | |
| SSPKALNFGGIGVVV | 591 | P42892 | |
| SPGQAERVSVGKAGT | 436 | Q7Z2K8 | |
| AGPSGQGDSVSIGKV | 561 | Q7Z2K8 | |
| QGDSVSIGKVVSTPG | 566 | Q7Z2K8 | |
| IAGVIGPGSSSVAIQ | 156 | Q13255 | |
| ASAGVSPQGAGLVIQ | 276 | Q9NZM4 | |
| AGQGLIVVISSPGSL | 141 | Q96LJ7 | |
| GPVGTGKTSIAQSVL | 2416 | Q9P225 | |
| IGGIATLTGTAPNLV | 231 | Q13183 | |
| GQPGALSGTTSVLIK | 231 | Q9H159 | |
| VKTETISFGSVSPGG | 951 | Q9Y2J2 | |
| AASQQGPGLGKESIT | 111 | Q05469 | |
| TGQAGKFGLIPTAVT | 326 | O15547 | |
| GIGQDSPTGKSNILV | 181 | Q0VDF9 | |
| TDKIVVGSSVAPGNT | 221 | P49757 | |
| VKSVQPEVELSSGGG | 6 | Q8NEY1 | |
| TKSAGPGQVTTALAG | 301 | Q8TC56 | |
| GLTGAVNVAKGTVQT | 491 | Q96Q06 | |
| TVTTGLVGAVNVAKG | 586 | Q96Q06 | |
| VTGAVNVAKGTVQTG | 921 | Q96Q06 | |
| VTGTQAASPNVGALK | 216 | Q5VT97 | |
| VGGAVVTGVTAVAQK | 66 | P37840 | |
| GPVGAKAGVVTLHSV | 401 | Q92750 | |
| PAGNAATVRKGSSTV | 126 | Q96KT7 | |
| GSTVATGKNGDTLPL | 361 | Q969X6 | |
| PAGNAATVRKGSSTV | 126 | Q8N808 | |
| PGLIIATGSVGKNLA | 501 | Q92673 | |
| AVGGIANATIGAVSP | 581 | Q02446 | |
| GGGALSAVAATKSPI | 256 | P61011 | |
| STGLKAINVEGPVQG | 541 | Q3ZLR7 | |
| INKVGIGLVAAASSP | 501 | P12757 | |
| QPTAGGTSKNEGTIT | 1041 | Q8WXH0 | |
| AASVPVKGSLGQGTA | 726 | Q13428 | |
| GGGKVVSVQAASVPI | 561 | Q14934 | |
| VVGPVGAGKSSLLSA | 661 | O95255 | |
| DVGSVKRVTSGPSLG | 496 | Q13393 | |
| QRLVVQSAAPGSKGG | 176 | P22670 | |
| QSAAPGSKGGQVSLT | 181 | P22670 | |
| ATALTAGGTGAKVPS | 401 | Q9Y606 | |
| PKGDIGGTQSTQILA | 36 | Q5VWT5 | |
| GVVGLPNVGKSSLIN | 256 | Q9NVN8 | |
| VTPGSGALQGQSVSV | 2976 | P58107 | |
| VTPGSGALQGQSVSV | 4041 | P58107 | |
| LQDQKVVLSSGSGPG | 281 | P04278 | |
| VGSALAPGATVKAEG | 16 | A0A1B0GUA5 | |
| GVTSQFVSKNGPGTV | 711 | Q92835 | |
| PAQGHKGTSVIITNG | 751 | P81133 | |
| SGSPIVTGVALQQGK | 546 | Q8N196 | |
| AGEGLFSKVAVGPNT | 226 | Q8WTS6 | |
| ASIANIVKSSLGPVG | 26 | P17987 | |
| KSVVPGGGAVEAALS | 406 | P17987 | |
| LVGPNGSGKSTVAAL | 536 | Q03518 | |
| LVGPNGSGKSTVAAL | 501 | Q03519 | |
| KGPAGSQVTLSSLGN | 406 | Q9P202 | |
| VGGGSSPKFSEISVL | 66 | Q9Y484 | |
| EVVVAVGFPGAGKST | 366 | Q96T60 | |
| AGGSKPRDVTNFTVG | 646 | O00267 | |
| ISAGAVQTAGKKGPQ | 81 | P46087 | |
| STGNAGQVPAVGGIK | 691 | Q9NRH2 | |
| PVVVASGGTGPLSQK | 36 | Q9BR10 | |
| SGGTGPLSQKAEQVA | 41 | Q9BR10 | |
| TLPAGTEKQVVGAGL | 801 | P98171 | |
| LKEGQGTSVVAQGPS | 46 | Q9UL12 | |
| QKLQGNGVAGSPSVV | 541 | Q7Z6J0 | |
| TGLKATNVEGPVRGA | 571 | P0C7V6 | |
| AGGVTAVGSAVVNKV | 91 | Q8WUH6 | |
| LLGAPTGSGKTVAAE | 1346 | Q8N3C0 | |
| QEVKASTLSPGGGVT | 366 | Q63HN8 | |
| STVGVPGTGKSTLLN | 696 | Q8TCY9 | |
| GIFISPKGVLQNTGS | 61 | Q9UPY5 | |
| IGGKPQDIIFTSGGT | 86 | Q96I15 | |
| TGVGGVAVTSSPFTK | 911 | Q5TCY1 | |
| TPATGTTQGKKAEGT | 191 | Q9P2E9 | |
| SSPNIGVLGITKVGS | 441 | Q9UGH3 | |
| SSSPNIGVLGITKVG | 381 | Q9UHI7 | |
| AGGISGTVAAVLTLP | 261 | Q9BZJ4 | |
| TGGKTQVAGIISAAI | 416 | O43511 | |
| VLISFGAVLGKTGPT | 136 | Q9H310 | |
| SVGKVTENGGSPQGI | 26 | Q92766 | |
| IPDISQKSENGGVGS | 756 | Q9BQI5 | |
| NNVVGGSPLAKGITT | 536 | Q8TEJ3 | |
| ATRSPVGAGTKLNSV | 56 | Q5TF21 | |
| VKLTGGGGNVTLTLP | 201 | Q02086 | |
| TLQPGVNSGAVILGK | 326 | Q8N0Z6 | |
| IIGPNGSGKSNVIDS | 111 | Q9NTJ3 | |
| QVSSIPIISGGTKGL | 846 | Q709C8 | |
| APVQGTAHVVKGGAT | 596 | P78364 | |
| KGGATTSSPVVAQVP | 606 | P78364 | |
| GKTEGSTAGAQIPSK | 606 | Q2KHR2 | |
| TGAGSGVKSEPQFIQ | 856 | Q9Y6N7 | |
| SATVKPGAVGAGEFV | 1686 | Q12888 | |
| VKELVGSVGGAVTFP | 26 | Q9NQ25 | |
| GIVGYVKTGSVPSLA | 26 | Q9NUH8 | |
| PTVVKGVAGGSVAVL | 356 | P01833 | |
| PAGNAATVRKGSSTV | 126 | P0C7Q6 | |
| TVKEATAGNPGGQTV | 356 | P27708 | |
| GGTAVPTSQKVKEAG | 91 | Q9BVV7 | |
| AGKTVVGVPSGKVSS | 196 | Q96GY0 | |
| GETGSGKTTQIPQFL | 216 | Q9H6S0 | |
| PALGKGEGAITSSAI | 631 | Q8N1G0 | |
| VVGKGVFGSLSSAPA | 1106 | Q9Y4F4 | |
| SLPGAGGNIRTATAK | 1666 | Q9Y4F4 | |
| GVSQVKEGPVLATSS | 1836 | Q9H4A3 | |
| KEGPVLATSSGAGVF | 1841 | Q9H4A3 | |
| GFEPGVTNILKTTQG | 576 | Q15063 | |
| TVIQAAGGVPGSTVT | 171 | Q9Y462 | |
| AGGVPGSTVTIKTED | 176 | Q9Y462 | |
| GATVASVPLSLQVGG | 741 | Q04912 | |
| PSGSGQEVGGQTAVK | 1596 | Q702N8 | |
| DNVFITGPTGSVKIG | 306 | Q96J92 | |
| QETPATKKAVQGGGA | 116 | P09012 | |
| TKKAVQGGGATPVVG | 121 | P09012 | |
| SSGAGGQPNITKLII | 356 | O94842 | |
| SPGFGVKQIATGVSD | 126 | P25942 | |
| SNVPKVVGSAVGSGS | 201 | Q9Y5A9 | |
| AKKQGPVATGVSGDA | 1011 | Q9BVV6 | |
| KPSGAISGVQKAENG | 241 | Q9UHD2 | |
| GADSTGVVAKLSPAN | 686 | Q13263 | |
| VFVGTAGTVGRPKNA | 121 | Q86VY4 | |
| FAIGPSTGGAIVKAI | 441 | P54219 | |
| ATSGLVPGGINVTTA | 771 | P98155 |